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Zusammenfassung 
Einleitung 
Beschreibung der Technologie und der Komparatoren 
Der vorliegende EUnetHTA Bericht bewertet 3D-gedruckte, maßgefertigte o-
der individualisierbare Implantate und Schnittschablonen, die bei erwachse-
nen PatientInnen (>18 Jahre) bei Knie-, Maxillofazial (Mund, Kiefer, Gesicht)- 
oder Schädelchirurgie verwendet werden können. Vom 3D-Druck wird er-
wartet, dass individualisierbare und personalisierte Implantate und Schnitt-
schablonen, die von 3D-Druckgeräten hergestellt wurden, eine bessere Wirk-
samkeit, Sicherheit und Leistungsfähigkeit haben.  
Definitionen unterschiedlicher 3D-Produkte: 
b Maßgefertigtes Medizinprodukt („custom-made medical device“): je-
des Produkt, das speziell basierend auf der Verordnung eines/r qua-
lifizierten Arztes/Ärztin hergestellt wird und das unter seiner/ihrer 
Verantwortung spezifische Konstruktionsmerkmale aufweist und für 
die alleinige Verwendung durch eine/n bestimmte/n PatientIn be-
stimmt ist.  
 
b Individualisierbares Medizinprodukt („customisable medical de-
vice“): Medizinprodukte, die Standardprodukte sind und individuell 
an die Eigenschaften eines/r bestimmten PatientIn angepasst wer-
den.  
b Schnittschablone („cutting guide/surgical guide“): eine Schnittschab-
lone ist ein kleines, individuelles Werkzeug aus einem sterilisierbaren 
Material, das kurzfristig bei einem/r PatientIn eingesetzt werden 
kann und die Säge und/oder den Bohrer in die geplante Richtung 
führt. 
Als Komparatoren dienen standardmäßige, nicht 3D-gedruckte Implantate o-
der Schnittschablonen. Da der 3D-Druck die Möglichkeit bietet, komplexe kli-
nische Fälle zu behandeln, für die es aufgrund ihrer Komplexität keine alter-
nativen Behandlungsmöglichkeiten gibt, wurde auch "keine Behandlung" o-
der „übliche Versorgung (Standard of Care)“ als Komparator gewählt.  
 
 
Gesundheitsproblem 
3D-gedruckte Medizinprodukte werden derzeit am häufigsten in der Knie-, 
Maxillofazial- und Schädelchirurgie eingesetzt. Die häufigsten Krankheiten, 
die in den eingeschlossenen Studien dargestellt wurden, sind: 
b Knie-Arthrose und sekundäre rheumatoide Arthritis, die mit totaler 
Kniearthroplastik (TKA) behandelt werden, 
b Mundkrebs, der durch Unterkieferrekonstruktion behandelt wird, 
b Traumatische Hirnverletzungen mit intrakranieller Hypertonie, die 
mit dekompressiver Kraniektomie und später mit Schädelplastik be-
handelt werden. 
Derzeit werden 3D-Drucktechnologien in Europa in nur ca. 1,3% von 
1.324.000 jährlichen TKAs eingesetzt. Darüberhinaus liegen zurzeit keine 
publizierten Daten über den Einsatz von 3D-Drucktechnologien bei der Un-
terkieferrekonstruktion und der Schädelplastik in Europa vor, aber es wird 
angenommen, dass ihr Einsatz in diesen klinischen Bereichen zunimmt.  
Population:  
PatientInnen (>18 Jahre) 
mit einer Knie-, Maxillofazial 
(Mund, Kiefer, Gesicht)- 
oder Schädeloperation 
 
Intervention:  
3D-gedruckte, 
maßgefertigte oder 
individualisierbare 
Implantate und 
Schnittschablonen 
 
Komparatoren: 
standardmäßige, nicht 
3D-gedruckte 
Implantate oder 
Schnittschablonen  
häufigste Krankheiten:  
 
Knie-Arthrose und 
sekundäre rheumatoide 
Arthritis,  
 
Mundkrebs,  
 
traumatische 
Hirnverletzungen mit 
intrakranieller 
Hypertonie 
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Methoden 
Für die Bewertung der klinischen Wirksamkeit wurde eine systematische Li-
teratursuche durchgeführt und die Studien gemäß der in diesem Bericht be-
schriebenen Ein- und Ausschlusskriterien ausgewählt. Die Suche erfolgte in 
zwei Schritten: zunächst wurde eine Suche nach systematischen Reviews 
(SRs) mit einer zeitlichen Beschränkung von fünf Jahren (April 2013-2018) 
durchgeführt. Des Weiteren wurde eine Suche nach Primärstudien (kontrol-
lierte klinische Studien, randomisierte kontrollierte Studien (RCTs) und Be-
obachtungsstudien) mit einer zeitlichen Beschränkung von zehn Jahren (Ap-
ril 2008-2018) vorgenommen. Für die Beschreibung der Technologie und des 
Gesundheitsproblems sowie der Sicherheit der Technologie wurden Informa-
tionen von der systematischen Literatursuche, klinischen und technischen 
ExpertInnen, aus EUnetHTA Dossiers von relevanten Herstellern und Inter-
net-Recherchen zu diesem Thema herangezogen. Die Literaturauswahl und 
Datenextraktion wurde von zwei ForscherInnen unabhängig voneinander 
durchgeführt.  
b Die Qualität der eingeschlossenen SRs wurde mit dem „Risk of Bias in 
Systematic Reviews (ROBIS)“ Tool bewertet.  
b Das „Cochrane Risk of Bias“ (RoB2) Tool wurde verwendet, um die 
Qualität der eingeschlossenen RCTs zu bewerten.  
b Das Bias-Risiko bei Kohorten- und Fallkontrollstudien wurde anhand 
von Checklisten zur Methodik vom „Scottish Intercollegiate Guide-
lines Network (SIGN)“ bewertet.  
b Für die Bewertung der Qualität der Evidenz wurde GRADE („Grading 
of Recommendations, Assessment, Development and Evaluation“) 
verwendet. 
Auch die Qualitätsbewertung wurde von zwei ForscherInnen unabhängig 
voneinander durchgeführt. Wo es möglich war, wurden für die Bewertung der 
klinischen Wirksamkeit Berechnungen mittels einer Metaanalyse im Review 
Manager (RevMan Version 5.3, The Cochrane Collaboration) durchgeführt.  
 
 
Ergebnisse 
Die Endpunkte hinsichtlich klinischer Wirksamkeit und Sicherheit in diesem 
Bericht waren:  
 
Endpunkte für PatientInnen, die sich einer Kniearthroplastik unterzogen: 
Primäre Endpunkte:  
b “Patient Reported Outcome Measures (PROMs)”:  
o Schmerzen gemessen mit dem „Visual Analogue Scale 
(VAS)“ oder „Numerical Pain Ranking Scale (NPRS)“ 
o Gesundheitsbezogene Lebensqualität (QoL) - (generisch 
oder krankheitsspezifisch)  
o PatientInnenzufriedenheit 
b Postoperative Funktion/Leistung, gemessen durch validierte Tests, 
d.h. „Timed-Up-and-Go-Test“, Treppensteige-Test („Stair Climb 
Test“) oder 6-minütiger Gehtest.  
b Funktion gemessen durch validierte klinische Ergebniswerte, d.h. 
Knieverletzung und Osteoarthritis Outcome Score oder Funktions-
skala der unteren Extremitäten. 
Sekundäre Endpunkte:  
b Operationszeit (in Bezug auf die Risikominimierung von Infektionen, 
Ischämie und Blutverlust) 
systematische 
Literatursuche, 
Involvierung von 
klinischen und 
technischen 
ExpertInnen,  
EUnetHTA Dossiers von 
relevanten Herstellern 
und  
Internet Recherchen 
ROBIS Tool 
 
Cochrane Risk  
of Bias Tool 
 
Checklisten von SIGN 
 
GRADE 
klinische Wirksamkeit: 
Metaanalyse (RevMan) 
primäre und sekundäre  
Endpunkte für 
Kniearthroplastik, 
Maxillofazial-Chirurgie, 
Schädelchirurgie 
  
b Gesamte Ausrichtung/Position („alignment“) der Extremitäten (von 
funktioneller Relevanz)  
b Strapazierfähigkeit des Produktes 
b Langlebigkeit des Produktes 
b Unerwünschte Ereignisse 
 
Endpunkte für PatientInnen, die sich einer Maxillofazial-Chirurgie unterzo-
gen: 
Primäre Endpunkte:  
b “Patient Reported Outcome Measures (PROMs)”:   
o Die Mundgesundheit gemessen auf validierten spezifischen 
Ergebnisskalen, z.B. dem „Oral Health Impact Profile 
(OHIP-14)“ oder der „United Kingdom Oral Health-Related 
Quality of Life Measure“ (OHQoL-UK).  
o Gesundheitsbezogene Lebensqualität (QoL) - (generisch 
oder krankheitsspezifisch)  
o Schmerzen gemessen mit VAS oder NPRS 
o PatientInnenzufriedenheit 
 
Sekundäre Endpunkte:  
b Operationszeit (in Bezug auf die Risikominimierung von Infektionen, 
Ischämie und Blutverlust) 
b Menge der Knochenentnahme („bone harvest“) während der Opera-
tion 
b Strapazierfähigkeit des Produktes 
b Langlebigkeit des Produktes 
b Unerwünschte Ereignisse 
 
Endpunkte für PatientInnen, die sich einer Schädelchirurgie unterzogen: 
Primäre Endpunkte:  
b “Patient Reported Outcome Measures (PROMs)”:    
o Gesundheitsbezogene Lebensqualität (QoL) - (generisch 
oder krankheitsspezifisch)  
o Schmerzen gemessen mit VAS oder NPRS 
b Präzision/Genauigkeit (von kosmetischer/ästhetischer und funktio-
neller Relevanz) 
b PatientInnenzufriedenheit 
 
Sekundäre Endpunkte:  
b Operationszeit (in Bezug auf die Risikominimierung von Infektionen, 
Ischämie und Blutverlust) 
b Strapazierfähigkeit des Produktes 
b Langlebigkeit des Produktes 
b Unerwünschte Ereignisse 
 
primäre und sekundäre  
Endpunkte für 
Maxillofazial-Chirurgie 
primäre und sekundäre  
Endpunkte für 
Schädelchirurgie 
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Verfügbare Evidenz 
 
Dreizehn Studien erfüllten die Einschlusskriterien: sechs RCTs und zwei SRs 
berichteten über PatientInnen, die sich einer Knierekonstruktion unterzogen 
hatten; drei RCTs und eine prospektive Studie involvierten PatientInnen bei 
denen eine Operation im Maxillofazialbereich durchgeführt wurde (insbeson-
dere PatientInnen mit einer Unterkieferrekonstruktion); und eine prospek-
tive Studie untersuchte PatientInnen mit einer Schädelplastik.  
 
Sechs Studien wurden in die quantitative Metaanalyse miteinbezogen. Alle 
Studien zur klinischen Wirksamkeit wurden auch für Aussagen zur Sicherheit 
eingeschlossen, ebenso wie drei weitere Studien, welche über Sicherheitsbe-
denken in der Maxillofazial- und Schädelchirurgie berichteten.  
 
Klinische Wirksamkeit 
Insgesamt war das Evidenzniveau der eingeschlossenen Studien sehr niedrig 
bis moderat, was hauptsächlich auf das Bias-Risiko und die geringe Präzision 
der Effektschätzer (weite Konfidenzintervalle) in den eingeschlossenen Stu-
dien zurückzuführen ist. Die sehr niedrige oder niedrige Qualität der Evidenz 
zeigte, dass  
b die 3D-Operation mit 3D-Druckimplantaten und Schnittschablonen in 
der TKA im Vergleich zu Standardimplantaten und Schnittschablonen 
präziser war, wie durch die Endpunkte Fehlstellung (Hüft-Knie-Schen-
kel-Winkel, koronale Oberschenkel-Ausrichtung und koronale Schien-
bein-Ausrichtung) oder absolute Abweichungen gezeigt wurde. 
b darüberhinaus keine weiteren klinisch relevanten oder signifikanten 
Ergebnisse oder Endpunkte zugunsten der 3D-Drucktechnologie oder 
der Standardoperation für die anderen Indikationen berichtet wurden.  
Solange keine qualitativ hochwertigere Evidenz vorliegt, kann keine endgül-
tige Entscheidung über den weiteren Einsatz der 3D-Drucktechnologie getrof-
fen werden. Es sind weitere Evaluierungen der 3D-Technologien und Opera-
tionen notwendig. 
 
Sicherheit 
Die Sicherheit der 3D-gedruckten Implantate und Schnittschablonen wurde 
in einigen der eingeschlossenen Studien im Vergleich zu Standardimplantaten 
und Schnittschablonen untersucht. Es wurden keine Unterschiede bei den 
Komplikationen der Technologien zur TKA, Unterkieferrekonstruktion und 
Schädelplastik berichtet, wohingegen ein Unterschied in der ischämischen 
Zeit bei der Unterkieferrekonstruktion beobachtet wurde: die ischämische 
Zeit war in der Gruppe mit individuellen, 3D-gedruckten, chirurgischen 
Schablonen im Vergleich zur Standardrekonstruktionsgruppe kürzer.  
 
Die Daten in diesen Studien beschrieben allerdings nur die kurzfristigen End-
punkte wie Infektion, venöse Thromboembolien, Hämarthrose, Ischämie und 
Operationszeit. Keine Aussagen können zu langfristigen Sicherheitsendpunk-
ten gemacht werden. 
 
klinische Wirksamkeit:  
13 Studien eingeschlossen 
(2 SRs, 9 RCTs, 2 
prospektive Studien) 
 
Sicherheit: plus 3 Studien 
 
quantitative Metaanalyse: 
6 Studien eingeschlossen 
Evidenzniveau der 
eingeschlossenen Studien 
sehr niedrig bis moderat 
 
3D-Druckimplantate und 
Schnittschablonen in der 
TKA im Vergleich zu 
Standardimplantate und 
Schnittschablonen präziser 
 
keine weiteren klinisch 
relevanten oder 
signifikanten Endpunkte 
zugunsten der 3D-
Drucktechnologie oder der 
Standardoperation 
 
keine Unterschiede bei 
den Komplikationen der 
Technologien zur TKA, 
Unterkiefer-
rekonstruktion und 
Schädelplastik,  
Unterschied in der 
ischämischen Zeit bei 
der Unterkiefer-
rekonstruktion 
 
  
Organisatorische und rechtliche Aspekte  
Organisatorische Veränderungen  
Organisatorische Veränderungen sind unvermeidlich, wenn 3D-gedruckte 
Implantate und Schnittschablonen als Ergänzung oder Ersatz für Standard-
Implantate und Schnittschablonen eingesetzt werden. Diese Veränderungen 
bestehen im Wesentlichen aus Änderungen im Arbeitsablauf in der Kranken-
hausabteilung sowie aus Änderungen in den Kompetenzen des Personals. Die 
Auswirkungen dieser Veränderungen hängen vom implementierten Organi-
sationsszenario ab. 
 
Anforderungen an den Marktzugang  
 
Derzeit gelten individualisierbare Medizinprodukte als verschreibungspflich-
tige Produkte, die für den/die einzelne/n PatientIn hergestellt werden, auch 
wenn sie manchmal das Potenzial haben, in Serie hergestellt zu werden. Daher 
werden sie in der Regel im Hinblick auf den Marktzugang als maßgefertigte 
Produkte klassifiziert. Im Gegensatz zu "Standard"-Medizinprodukten benöti-
gen Hersteller von maßgefertigten Produkten, unabhängig vom Risikoprofil 
und gemäß der Medizinprodukteverordnung, keine CE-Kennzeichnung für ihr 
Produkt.  
  
Haftung  
 
Nach den Grundsätzen der Produkthaftung, haftet der Hersteller für jeden 
Mangel an seinem Produkt. Der 3D-Druck weicht von der traditionellen Kette 
aus Produktion, Vertrieb und Nutzung ab. Einerseits ist der Hersteller schwer 
zu identifizieren, da in den meisten Fällen viele Parteien an der Herstellung 
von 3D-Druckgeräten beteiligt sind. Andererseits ist die Gesetzeslage von 
maßgefertigten oder individualisierbaren 3D-Druckimplantaten und Schnitt-
schablonen aufgrund von Regelungslücken unklar. Bei 3D-Druckern ist die 
Großserienproduktion eine Option, aber die aktuelle Verordnung berücksich-
tigt diese Möglichkeit nicht. Obwohl das Haftungsprinzip für 3D-Druckimp-
lantate und Schnittschablonen anwendbar ist, gilt dies nicht für den Fall der 
Großserienproduktion.  
 
Schutz personenbezogener Daten  
 
Das 3D-Druckverfahren beinhaltet zwangsläufig auch die Verarbeitung der 
Gesundheitsdaten der/des einzelnen PatientIn. Das Datenschutzgesetz 
schützt die Verarbeitung personenbezogener Daten und enthält entspre-
chende Regeln. Es ist wichtig zu wissen, wer von der/dem GesetzgeberIn als 
„für die Verarbeitung verantwortliche Person" angesehen wird.  
Laufende Studien  
Derzeit laufen drei Studien: ein RCT zur Untersuchung maßgefertigter Mo-
delle für das Biegen von Gesichtsschädel-Implantaten (Rekrutierung noch  
nicht begonnen), ein RCT zur Überprüfung personalisierter Oberkieferfixati-
onsplatten (Rekrutierung im Gange) und eine Interventionsstudie ohne Ran-
domisierung, welche die Verwendung von patientenspezifischen Titanplatten 
für die Kieferchirurgie testet (Rekrutierung noch  nicht begonnen). 
  
Änderungen im 
Arbeitsablauf und in den 
Kompetenzen des 
Personals 
 
individualisierbare 
Medizinprodukte in der 
Regel als maßgefertigte 
Produkte klassifiziert: 
bisher keine CE-
Kennzeichnung für 
maßgefertigte Produkte 
notwendig 
Haftungsprinzip für 3D-
Druckimplantate und 
Schnittschablonen 
anwendbar - gilt nicht 
für den Fall der 
Großserienproduktion 
 
Regelungslücken 
Verarbeitung der 
Gesundheitsdaten 
notwendig  
3 laufende Studien (2 
RCTs und 1 
Interventionsstudie) 
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Diskussion 
Diese Bewertung vergleicht die 3D-Operation mit 3D-gedruckten Implantaten 
und Schnittschablonen mit der entsprechenden Standardoperation in den 
drei Bereichen: Knie-, Maxillofazial- und Schädelchirurgie. Die Analyse zeigte 
eine signifikant höhere Präzision bei der 3D-Operation im Vergleich zur Stan-
dardoperation bei TKA, gemessen an den Endpunkten Fehlstellungen oder ab-
solute Abweichungen. Die Qualität der Evidenz war jedoch sehr gering bis mo-
derat. Diese Ergebnisse sind statistisch signifikant in Bezug auf das Ausmaß 
der Veränderung. Darüberhinaus liegen keine weiteren statistisch signifikan-
ten Ergebnisse zugunsten einer 3D- oder Standardoperation bei anderen End-
punkten oder anderen Indikationen.  
Relevante Endpunkte (Ausrichtung) sind Proxy-Endpunkte und lassen keine 
Aussagen auf eine zukünftige, direkte Auswirkung auf die/den PatientIn zu, 
wie z.B. verminderte Schmerzen oder erhöhte Lebensqualität (QoL). Zukünf-
tige Studien müssen einen eindeutigen Zusammenhang zwischen Fehlstellun-
gen und langfristigen patientenrelevanten Endpunkten herstellen, und Me-
thoden zur Messung der Ausrichtung müssen weiter validiert werden. Ob-
wohl es keine Unterschiede in den Komplikationen zwischen den Technolo-
gien beobachtet wurden, müssen langfristige Komplikationen wie Implantat-
versagen, Prothesenprobleme und anhaltende Schmerzen weiter und umfas-
send evaluiert werden, um festzustellen, welche Sicherheitsprobleme durch 
die Einführung dieser neuen Technologie auftreten können. 
Die wichtigste rechtliche Frage im Zusammenhang mit der 3D-Drucktechno-
logie ist, ob die individualisierbaren Medizinprodukte mit einer CE-Kenn-
zeichnung versehen werden müssen oder nicht. Neue EU-Verordnungen ver-
schärfen die Anforderungen an 3D-gedruckte Medizinprodukte, die in größe-
ren Stückzahlen hergestellt werden, aber in vielen Fällen gelten individuali-
sierbare Produkte als individuelle, maßgefertigte Produkte und unterliegen 
daher nicht einer CE-Kennzeichnung, obwohl sie oft in Standardproduktions-
prozessen hergestellt werden. Dies bedeutet, dass individualisierbare Medi-
zinprodukte möglicherweise die gleichen Bedingungen für den Marktzugang 
erfüllen müssten wie Standard-Medizinprodukte. Trotz der neuen Verord-
nungen (MDR/ IVDR) bestehen derzeit (und in Zukunft) unterschiedliche ge-
setzliche Anforderungen für die verschiedenen Arten der 3D-gedruckten Me-
dizinprodukte sowie für die 3D-gedruckten Medizinprodukten im Vergleich 
zu deren Komparatoren (Standard-Medizinprodukten).  
Die Herausforderung bei der Identifizierung der Verantwortlichen für die 3D-
Druckgeräte bleibt bestehen, da sich der Hersteller des 3D-Druckers und der 
Hersteller der Produkte in den meisten Fällen unterscheiden, obwohl die Haf-
tung nach geltendem Recht klar ist und für alle Beteiligten gilt.  
Schlussfolgerung 
Die sehr niedrige bis niedrige Qualität der Evidenz zeigt signifikante Unter-
schiede in der Präzision in Bezug auf Fehlausrichtung und Abweichung zwi-
schen der 3D-Drucktechnologie und der Standardinstrumente in der TKA. Um 
diese signifikanten Ergebnisse zu validieren und endgültige Schlussfolgerun-
gen ziehen zu können, ist eine Evidenz von höherer Qualität erforderlich. Bei 
der Unterkieferrekonstruktion und der Schädelplastik lassen sich keine ein-
deutigen Schlussfolgerungen ziehen, da es keine signifikanten Endpunkte zu-
gunsten einer von beiden Technologien gab. Was die Sicherheit betrifft, so 
wurde zwar über einige kurzfristige Endpunkte wie Infektion, venöse Throm-
boembolien und Hämarthrose berichtet, aber es wurden keine Unterschiede 
abseits der ischämischen Zeit bei der Unterkieferrekonstruktion zwischen 
den untersuchten Technologien beobachtet. 
Evidenz: sehr gering bis 
moderat 
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1   SUMMARY OF RELATIVE EFFECTIVENESS OF 3D PRINTED CUSTOM-
MADE OR CUSTOMISABLE IMPLANTS AND CUTTING GUIDES VERSUS 
NON-3D PRINTED STANDARD IMPLANTS AND CUTTING GUIDES 
1.1   Scope 
The scope of this assessment is 3D printed custom-made or customisable implants and cutting 
guides used in adult patients (>18 years) undergoing knee, maxillofacial, or cranial surgery. Com-
parators of interest are standard non-3D printed implants or cutting guides. 3D printing offers the 
opportunity to treat complex clinical cases with no alternative treatments available due to their 
complexity. In these cases, where no standard solutions are available, the comparison is "no 
treatment" or "usual care”. The scope can be found here. 
1.2   Introduction 
Description of technology and comparators  
The technology described in this assessment is the use of 3D print technology to produce custom-
made or customisable 3D printed implants and cutting guides versus non-3D printed standard 
implants and cutting guides for improving outcomes in patients undergoing knee, maxillofacial, or 
cranial surgery. The claimed benefit of 3D printed devices is the production of customisable and 
personalised guides and implants that subsequently improve safety, performance, and effective-
ness.  
Health problem 
3D printed medical devices are currently most frequently applied in knee, maxillofacial, and crani-
al surgery. The most frequent diseases represented in the included studies are knee osteoarthritis 
(OA) and secondary rheumatoid arthritis treated with total knee arthroplasty (TKA), oral cancer 
treated by mandibular reconstruction, and traumatic brain injury (TBI) with intracranial hyperten-
sion (ICH) treated with decompressive craniectomy (DC) and later cranioplasty. Each year world-
wide, approximately 1% of the population contacts a doctor with symptoms of knee arthritis, oral 
cancer affects over 300,000 people, and TBI over 10 million people. In Europe, 3D printing tech-
nologies are currently used in only ~1.3% of 1,324,000 annual TKAs (1,2). There are currently no 
published data on the utilization of 3D printing technologies in mandibular reconstruction and cra-
nioplasty in Europe, but its use is known to be increasing in these clinical areas. 
1.3   Methods  
A systematic literature search was performed for the effectiveness domain (EFF) of this assess-
ment. The search met the inclusion and exclusion criteria described in the Scope of this assess-
ment. The search was performed in two steps. First, a search for systematic reviews (SRs) was 
performed with a time limit of five years (April 2013-2018). Second, a search for primary studies 
was performed with a time limit of ten years (April 2008-2018) including controlled clinical trials, 
randomised controlled trials (RCTs), and observational studies. For the technical characteristics 
(TEC), current use (CUR), and safety (SAF) domains, information was identified through the sys-
tematic literature search, clinical and technical experts, manufacturer submission files, and inter-
net searches on the topic. Literature selection and data extraction were performed independently 
by two researchers.  
The quality of the included reviews was assessed using the Risk of Bias in Systematic Reviews 
(ROBIS) tool. The Cochrane risk-of-bias (RoB2) tool was used to assess the quality in the inclu-
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ded RCTs. Risk of bias in cohort and case-control studies was assessed using Scottish Intercol-
legiate Guidelines Network (SIGN) methodology checklists. The quality of the body of evidence 
was assessed using Grading of Recommendations, Assessment, Development and Evaluations 
(GRADE). Quality assessment was performed independently by two researchers. For the EFF 
domain, statistical summary estimates of associations across studies were where possible de-
rived through a random effects meta-analysis using Review Manager (RevMan version 5.3, The 
Cochrane Collaboration). 
1.4   Results 
The findings are summarised in Table 1.1. 
Available evidence 
Thirteen studies met the inclusion criteria: six RCTs and two SRs reported on patients undergoing 
knee reconstruction; three RCTs and one prospective study reported on maxillofacial patients 
(specifically, patients undergoing mandibular reconstruction); and one prospective study exa-
mined patients undergoing cranioplasty. The study characteristics are detailed in Table A.1 and 
Table A.2. Six studies were included in the quantitative meta-analysis. All studies from the EFF 
domain were included in the SAF domain together with three additional studies regarding safety 
concerns in maxillofacial and cranial surgery.  
Clinical effectiveness 
Overall, the evidence level for the included studies was very low to moderate, mainly due to the 
risk of bias and the imprecision of the estimates in the included studies. Therefore, the robustness 
of the findings may be limited. There was very low or low quality evidence showing that 3D sur-
gery using 3D printed implants and cutting guides in TKA compared with standard instrumentation 
was more precise, as demonstrated through outcomes such as malalignment (hip-knee-ankle 
angle, coronal femoral alignment, and coronal tibial alignment) or absolute deviation. There were 
no other clinical relevant or significant results or outcomes in favour of 3D print technology or 
standard surgery. Consequently, 3D surgery requires further evaluation. Until higher quality evi-
dence is generated, no final decision on the continued use of 3D print technology can be made. 
Safety  
Safety issues related to 3D printed implants and cutting guides compared with standard implants 
and cutting guides were examined in a few of the included studies. There was no overall diffe-
rence in complications between the technologies in TKA, mandibular reconstruction, and cranio-
plasty. There was a difference in ischaemic time in mandibular reconstruction, with a decrease in 
ischaemic time in the group using individual 3D printed surgical guides compared to the standard 
reconstruction group. The data in these studies described only short-term outcomes such as in-
fection, venous thromboembolism, haemarthrosis, ischaemia, and operating time.  
Organisational and legal aspects  
Organisational changes  
Organisational changes are inevitable if 3D printed implants and surgical guides are implemented 
as a supplement to or as a replacement for standard implants and surgical guides. These chan-
ges will mainly consist of workflow changes in the hospital department and competency changes 
for personnel. The impact of these changes will depend on the organisational scenario imple-
mented. 
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Requirements for market access 
Currently, customisable devices are regarded as prescription devices made for individual patients, 
even though they sometimes have the potential to be mass produced. As a consequence, they 
are usually classified together with custom-made devices with respect to market access. In con-
trast to "standard" medical devices, manufacturers of custom-made medical devices, regardless 
of the risk profile and according to the Medical Device Directive, do not apply CE marking to their 
product.  
Liability 
According to the principles of product liability, the producer is liable for any defect in its product. 
3D printing deviates from the traditional chain of production, distribution, and use. On the one 
hand, the producer is difficult to definitively identify, since in most cases many parties are involved 
in 3D printed device production. On the other, the legalities of custom-made or customisable 3D 
printed implants and cutting guides remain unclear due to regulatory gaps. Manufacturer’s state-
ments are devoted to single or short series production of medical devices. In the case of 3D print-
ers, large-scale production is an option, but current regulation does not take this issue into ac-
count. Although the principles of liability are applicable to 3D printed implants and cutting guides, 
this does not cover the case of large-scale production.  
Protection of person data 
The 3D printing process unavoidably also involves the processing of the health data of the indi-
vidual patient. Privacy legislation protects the processing of personal data and has rules for this. It 
is very important to know who is regarded as "responsible for processing" by law. 
Upcoming evidence 
Three ongoing studies are detailed in Table A.3: two RCTs investigating custom-made models for 
bending implants (not yet recruiting) and personalised maxillary fixation plates (recruiting), and 
one intervention study without randomisation investigating the use of patient-specific titanium 
plates for jaw surgery (not yet recruiting).  
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Table 1.1: Summary of findings table for 3D printed implants and cutting guides 
Outcome Anticipated absolute effects (95% CI) Relative effect  
(95% CI) 
Number of 
participants  
(studies) 
Quality 
Risk with comparison Risk with 3D print technology 
Proportion of outliers (>3°) - hip-
knee-ankle alignment  
303 per 1.000  
112 per 1.000 
(65 to 185)  
OR 0.29 
(CI 0.16-0.52)  
319 
(4 RCTs)  
⨁⨁◯◯ 
LOW  
Absolute deviation in degrees  - 
The mean absolute deviation in 
degrees in the intervention 
group was 1.28 degrees lower 
(3.29 lower to 0.74 higher)  
-  
159 
(2 RCTs)  
⨁◯◯◯ 
VERY LOW  
Operating time  - 
The mean operating time in the 
intervention group was 9.47 
minutes lower (18.1 lower to 
0.84 lower)  
-  
239 
(3 RCTs)  
⨁⨁◯◯ 
LOW  
Oxford knee score (OKS) (1-
year follow-up)  
- 
The mean OKS (1-year follow-
up) in the intervention group was 
1.29 points higher (0.84 lower to 
3.41 higher)  
-  
289 
(2 RCTs)  
⨁⨁⨁◯ 
MODERATE  
Knee Society function score (3-
months follow-up)  
- 
The mean Knee Society function 
score (3-months follow-up) in 
the intervention group was 0 (0 
to 0)  
-  
240 
(2 RCTs)  
⨁⨁◯◯ 
LOW  
Proportion of outliers (>3°) - 
coronal femur  
214 per 1.000  
61 per 1.000 
(24 to 156)  
OR 0.24 
(CI 0.09- 0.68)  
319 
(4 RCTs)  
⨁⨁◯◯ 
LOW  
Proportion of outliers (>3°) - 
coronal tibia  
 172 per 1.000  
 57 per 1.000 
(24 to 126)  
 OR 0.29 
(CI 0.12-0.69)  
 319 
(4 RCTs)  
 ⨁⨁◯◯ 
LOW  
Proportion of outliers (>3°) - 
tibial slope  
209 per 1.000  
194 per 1.000 
(117 to 305)  
OR 0.91 
(CI 0.50-1.66)  
249 
(3 RCTs)  
⨁◯◯◯ 
VERY LOW  
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1.5   Discussion 
This assessment compared 3D surgery using 3D printed implants and cutting guides and stan-
dard surgery in three areas: knee, maxillofacial, and cranial surgery. The analysis showed signifi-
cantly greater precision with 3D surgery compared to standard surgery in TKA as demonstrated 
through outcomes such as malalignment or absolute deviation. However, the quality of evidence 
was only very low to moderate. These results are both statistically significant and also clinically 
significant in relation to the magnitude of change. There were no other statistically nor clinically 
significant results in favour of 3D or standard surgery. Relevant outcomes (alignment) are proxy 
outcomes, and do not necessarily indicate a future direct effect on the patient such as increased 
pain or decreased quality of life (QoL). Future studies need to establish a firm association be-
tween malalignment and long-term patient-relevant outcomes, and methods used to measure 
alignment need further validation. Although there were no overall differences in complications 
between the technologies, long-term complications such as implant failure, prosthesis problems, 
and continued pain need further, more extensive evaluation in order to recognize which safety 
issues this new technology could introduce.  
The main legal issues regarding 3D printed technology concern whether or not customisable de-
vices must be CE marked. New EU regulations impose stricter requirements for 3D printed medi-
cal devices made in larger quantities, but in many cases customisable devices are considered 
individual custom-made devices and therefore do not need to bear the CE mark even though they 
are often produced using standard production processes. This means that customisable medical 
devices may need to comply with the same conditions as standard medical devices for market 
access. Despite these new regulations, current (and future) different legal requirements exist be-
tween the different types of 3D printed medical devices and between 3D printed medical devices 
and the comparators (standard medical devices). Challenges remain in identifying who is respon-
sible for 3D printed devices, as the manufacturer of the 3D printer and the devices differ in most 
cases, notwithstanding that the liability under current law is clear and applies to all involved par-
ties. 
1.6   Conclusion 
Evidence of very low or low quality shows significant differences in precision in terms of 
malalignment and deviation between 3D printed technology and standard instrumentation in TKA. 
Evidence of higher quality is needed to validate these significant results and draw final conclu-
sions. No firm conclusions can be made in mandibular reconstruction and cranioplasty, since no 
outcomes were significant in favour of either technology. Regarding safety, while a few short-term 
outcomes such as infection, venous thromboembolism, and haemarthrosis were reported, there 
were no overall differences except from ischaemic time in mandibular reconstruction between the 
assessed technologies. 
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2   SCOPE  
Table 2.1: Scope according to population, intervention, comparison, outcomes, and study design 
analysis  
Description Project Scope 
Population  Adult patients (>18 years) undergoing knee, maxillofacial, or cranial surgery. 
Intervention  
 
The intervention under assessment is 3D printed custom-made or customisable im-
plants and cutting guides used in patients undergoing knee, maxillofacial, or cranial 
surgery (for product names see Table 4.3). 
The following MeSH terms are applied: Printing, Three-Dimensional; Stereolithography; 
Computer-Aided Design.  
Comparison 
 
Comparators of interest are standard non-3D printed implants or cutting guides. In 
some cases, 3D printing offers the opportunity to treat complex cases that have no 
alternative treatment due to complexity. In these cases, where no standard solutions 
are available, the comparison will be "no treatment" or "usual care". 
Outcomes Outcomes for patients undergoing knee arthroplasty 
Primary outcomes of interest: 
 Patient Reported Outcome Measures (PROMs):  
o Pain measured by the Visual Analogue Scale (VAS) or Numerical Pain 
Ranking Scale (NPRS) 
o Health-related QoL (generic or disease-specific) 
o Patient satisfaction 
 Post-operative function/performance measured by validated tests, i.e., Timed-
Up-and-Go Test, Stair Climb Test, or 6-Minute Walk Test. 
 Function measured by validated clinical outcome scores, i.e., Knee injury and 
Osteoarthritis Outcome Score or Lower Extremity Functional Scale 
Secondary outcomes of interest: 
 Operation time (in relation to minimising risk of infection, ischaemia, and blood 
loss) 
 Overall limb alignment (of functional relevance) 
 Durability of the device 
 Longevity of the device 
 Adverse events 
 
Outcomes for patients undergoing maxillofacial surgery 
Primary outcomes of interest: 
 PROMs: 
o Oral health measured by validated specific outcome scales, i.e., Oral 
Health Impact Profile (OHIP-14) or the United Kingdom Oral Health-
Related Quality of Life measure (OHQoL-UK) 
o Health-related QoL (generic or disease-specific) 
o Pain measured by VAS or NPRS 
o Patient satisfaction 
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Description Project Scope 
Secondary outcomes of interest:  
 Operating time (in relation to minimising risk of infection, ischaemia, and blood 
loss) 
 Amount of bone harvest used in surgery 
 Durability of the device 
 Longevity of the device 
 Adverse events 
 Outcomes for patients undergoing cranial surgery 
Primary outcomes of interest: 
 PROMs: 
o Health-related QoL (generic or disease-specific) 
o Pain measured by VAS or NPRS 
 Precision/accuracy (of cosmetic/aesthetic and functional relevance) 
 Patient satisfaction 
Secondary outcomes of interest:  
 Operating time (in relation to minimising risk of infection, ischaemia and blood 
loss) 
 Durability of the device 
 Longevity of the device 
 Adverse events 
Study design For the EFF and SAF domains, the following study types were eligible for inclusion: 
 High-quality SRs or meta-analyses of RCTs or controlled trials published with the 
last 5 years and RCTs or controlled trials published with the last 10 years 
 If the subject under assessment does not allow the possibility of an RCT or other 
controlled trial (e.g., the comparator is "no treatment"), evidence of lower quality 
was included in the assessment 
 Studies that compared different types of 3D printed implants or cutting guides 
were excluded. Studies addressing 3D printing of products incorporating bio-
materials like drugs, xenogenic cell therapy preparations, 3D printed drugs, or 
3D bioprinting (3D fabrication technology involving biological tissues, organs, 
and cells for medical and biotechnology applications) were also excluded 
For the TEC and CUR domains, the completed EUnetHTA submission files from the 
manufacturers were used as a starting point. Furthermore, information for these do-
mains was obtained from external experts with knowledge of the technology and litera-
ture (i.e., descriptive publications), the grey literature, and anecdotal information from 
general internet searches. Potential social, ethical, legal, and organisational aspects 
were identified through clinical experts and legal documents. 
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3   METHODS AND EVIDENCE INCLUDED  
3.1   Assessment Team 
Description of the distribution of the work between Authors and Co-authors: 
DEFACTUM - Social & Health Services and Labour Market (DEFACTUM) (Author): 
 Developed the first draft of the EUnetHTA project plan and amended the draft as necessary  
 Performed the literature search  
 Carried out the assessment of the health problem and current use of the technology (CUR), 
clinical effectiveness (EFF) and safety (SAF) domains  
 Completed the checklist regarding potential “Ethical, organisational, patient and social, and 
legal aspects” of the HTA Core Model
®
 for rapid REAs 
 Sent “draft versions” to reviewers and compiled feedback from reviewers and performed 
changes according to reviewers' comments on the CUR, EFF, and SAF domains 
 Prepared the final assessment and wrote a final summary of the assessment 
Basque Office for Health Technology Assessment (OSTEBA) (Co-author): 
 Reviewed draft of EUnetHTA project plan. Checked and approved all steps (e.g., literature 
selection, data extraction, assessment of risk of bias)  
 Carried out the assessment of the TEC domain and performed changes according to re-
viewers' comments on the TEC domain  
 Reviewed draft assessment, proposed amendments where necessary, and provided feed-
back on: information retrieval; sources and search terms for locating domain-specific infor-
mation; and inclusion/exclusion criteria for studies or other information in terms of content, 
methods and quality 
3.2   Source of assessment elements 
The selection of assessment elements was based on the HTA Core Model4
®
 Application for Ra-
pid Relative Effectiveness Assessments (REA) (4.2). The assessment elements were translated 
to research questions that would be addressed in the assessment. Additionally, assessment ele-
ments from other HTA Core Model
®
 Applications (for medical and surgical interventions, diagnos-
tic technologies, or screening) were screened and included/merged with the existing questions if 
deemed relevant. Furthermore, the checklist for potential ethical, organisational, patient and so-
cial, and legal aspects of the HTA Core Model
®
 for rapid REA was completed. 
3.3   Search 
A systematic literature search was performed for the effectiveness domain (EFF) of this assess-
ment. The search was performed to meet the inclusion and exclusion criteria described in the 
Scope of this assessment. The search was performed in two steps. First, a search for SRs was 
performed with a time limit of five years (April 2013-2018). Second, a search for primary studies 
was performed with a time limit of ten years (April 2008-2018) including controlled clinical trials, 
RCTs, and observational studies. No language restrictions were used in any of the searches.  
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The search strategy is detailed in Appendix 1. 
The following sources of information were used in the search: 
 The Cochrane Library (including The Cochrane Database of Systematic Reviews (CDSR), 
The Database of Reviews of Effects (DARE), The Cochrane Central Register of Controlled 
Trials, and The Cochrane Methodology Register) 
 EMBASE 
 PubMed 
 Manual searches (in the reference lists of relevant studies) 
In addition, the following clinical trial databases were searched to identify on-going studies on 
custom-made or customisable 3D printed implants and/or cutting guides:  
 ClinicalTrials.gov 
 EU Clinical Trials Register  
In addition to these systematic searches, clinical and technical experts were consulted to identify 
additional studies.  
For the TEC, CUR, and SAF domains, information was identified through the systematic literature 
search, clinical and technical experts, manufacturers’ submission files, and through internet 
searches on the topic.  
After removal of duplicates, literature selection was performed independently by two researchers 
from DEFACTUM using the inclusion/exclusion criteria and according to the research question 
and PICO scheme. Disagreements were resolved by consensus. The PRISMA flow diagram 
(Figure 3.1) display the phases of literature selection. 
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3.4   Study selection 
Figure 3.1: Flow chart of systematic literature search
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Additional records identified 
through other sources 
(n = 2) 
Records after duplicates removed 
(n = 582) 
Records screened 
(n = 582) 
Records excluded 
(n = 475) 
Full-text articles assessed 
for eligibility 
(n = 107) 
Full-text articles excluded 
(n = 94): 
 Language other than English, 
Danish, Norwegian or Swedish 
(n= 13) 
 Conference document or 
comment (n=7) 
 No standard control group (n=7)  
 Not systematic review (n=5) 
 Retrospective data (n=8) 
 Dublet (n=1) 
 Patient group or intervention not 
relevant (n=26) 
 Study not assessing or reporting 
effects (n=14) 
 Study included in systematic 
review (n=11) 
 Study not found (n=2) 
 
 
Studies included in 
qualitative synthesis 
(n = 13)  
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 6 ) 
 
The search generated 1079 records, which reduced to 582 after removal of duplicates. These 
studies were then screened by title and abstract to identify potentially relevant studies, resulting in 
107 eligible studies. Literature selection by full text review was conducted for the EFF and SAF 
domains at the same time, resulting in included 13 studies. This process was checked by the co-
authors (Osteba). 
3.5   Data extraction and analyses 
Data from the included studies were extracted using a standardised data extraction form (see 
Table A.1 and Table A.2). Data extraction was performed independently by two DEFACTUM 
researchers. The process was double-checked by the co-authors (Osteba). 
                                                     
1
 http://www.prisma-statement.org/ 
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For each outcome, an evidence profile was generated using the GRADEpro software
2
. Results 
from high-quality studies were given the most emphasis in the synthesis. Results were presented 
as a narrative synthesis. For the EFF domain, statistical summary estimates of associations 
across studies were if possible derived using random effects meta-analysis, anticipating clinical 
heterogeneity and with modelling allowing for differences in associations from study to study. 
Heterogeneity across studies was statistically assessed using the Q-test and quantified by the 
inconsistency (I
2
) index, where I
2
 represents the percentage of total variation across studies 
attributable to heterogeneity rather than (statistical) chance. In cases with substantial 
heterogeneity across studies (I
2
>50%), the robustness of the results was checked using a fixed 
effects model. A result was considered robust if the point estimate based on the fixed effects 
analysis was within the confidence interval of the random effects analysis. Meta-analyses were 
performed using Review Manager (RevMan, the Cochrane Collaboration). A two-sided p-value of 
<0.05 was considered to be statistically significant in all analyses. 
3.6   Quality rating  
Study and outcome validity and level of evidence were assessed according to EUnetHTA guide-
lines. In the EFF and SAF domains, the review was prepared in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement
3
. The quality of 
the included reviews was assessed using the Risk of Bias in Systematic Reviews (ROBIS) tool
4
. 
This tool assesses four domains to cover key review processes: study eligibility criteria; study 
identification and selection; data collection and study appraisal; and synthesis and findings. The 
Cochrane risk-of-bias tool was used to assess the quality of the included RCTs according to the 
EUnetHTA Guidelines on medical devices for study and outcome level. Risk of bias in cohort and 
case-control studies was assessed using Scottish Intercollegiate Guidelines Network (SIGN)
5
 
methodology checklists. The quality of the body of evidence was assessed using Grading of Re-
commendations, Assessment, Development and Evaluation (GRADE). The quality assessment 
was performed independently by two DEFACTUM researchers. The process was double-checked 
by the co-authors (Osteba). Any disagreement was resolved by consensus. For the TEC and 
CUR domains, no quality assessments were applied, but multiple sources were used to validate 
potentially biased sources. Descriptive analyses of different information sources were applied. 
3.7   Deviations from project plan 
In relation to outcomes, function in knee patients was measured using the Knee Society Score 
(KSS) and Oxford Knee Scale. No results were found regarding the durability and longevity of the 
devices, and patient satisfaction was not specified as an outcome in any study and was not re-
ported in any of the included RCTs or cohort studies. 
                                                     
2
 https://gradepro.org/ 
3
 http://www.prisma-statement.org/ 
4
 https://www.bristol.ac.uk/population-health-sciences/projects/robis/ 
5
 https://www.sign.ac.uk/checklists-and-notes.html 
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4   DESCRIPTION AND TECHNICAL CHARACTERISTICS OF TECHNOLOGY 
(TEC) 
The research questions for this assessment refer to two types of technologies: implants and cut-
ting guides for guiding surgical interventions. The intervention is 3D printed custom-made or cus-
tomisable implants and cutting guides, and the comparator is standard produced implants and 
cutting guides. The difference between the intervention and the comparator is related to the way 
in which the guides and the implants are produced: by moulding in the case of standard care and 
by 3D printing in the case of the intervention. 3D printing is a process by which 3D objects are 
created layer-by-layer from raw materials guided by a digital file.   
4.1   Research questions 
Element ID Research question 
B0001 
What are 3D printed implants and cutting guides versus standard implants and cutting 
guides? 
B0002 
What is the claimed benefit of 3D printed implants and cutting guides compared to stand-
ard implants and cutting guides? 
B0003 
What is the phase of development and implementation of 3D printed implants and cutting 
guides? 
B0004 
Who administers 3D printed implants and cutting guides and standard implants and cutting 
guides and in what context and level of care are they provided?  
B0008 
What kind of special premises are needed to use 3D printed implants and cutting guides 
and standard implants and cutting guides? 
B0009 
What equipment and supplies are needed to use 3D printed implants and cutting guides 
and standard implants and cutting guides? 
A0020 
For which indications have 3D printed implants and cutting guides received marketing au-
thorisation (FDA or CE marking)? 
 
Definitions 
Custom-made manufacturer - The natural or legal person who undertakes the design of the 
product and manufactures the device to a predefined specification (i.e., a prescription). 
Custom-made medical device - Any device specifically made in accordance with a duly qualified 
medical practitioner’s prescription which gives, under their responsibility, specific design charac-
teristics and is intended for the sole use of a particular patient. 
Customisable medical device - Medical devices that are standard and are customised or 
adapted to the characteristics of a particular patient. 
Cutting guide/surgical guide - A surgical guide is a small customised tool made from a sterili-
sable material that can be used short-term in a patient and that guides the saw and/or drill in the 
planned direction (https://www.xilloc.com/products_services/surgical-guides).  
4.2   Results 
3D printed and standard implants and cutting guides for knee, maxillofacial, and cranial replace-
ments do not differ very much with respect to materials and final product characteristics. The main 
difference is related to the production process and the possibilities for customisation offered by 3D 
printing.  
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Features of the technology and comparators 
[B0001] – What are 3D printed implants and cutting guides versus standard implants and 
cutting guides? 
Figure 4.1 shows the production flow and the seven basic steps required when using 3D printed 
guides or implants for tissue replacement (3). The only difference in the process compared to the 
standard procedure for developing the mould is in steps 2 and 4. In steps 2 and 4, software de-
sign and printing are used instead of the usual standard device moulds. The number of steps and 
difficulties in printing a 3D device are dependent on device complexity. A general sequence is 
described below and in Figure 4.1: 
Step 1. Device Design: This step consists of creating the most accurate model of the surfaces to 
be replicated and the volumes they refer to. In the case of 3D printing, this is achieved using ima-
ging modalities such as computerised tomography (CT), ultrasonography, and/or magnetic reso-
nance imaging (MRI). In the case of standard guides and implants, this is achieved using wax and 
soap models. 
Step 2. Software Design: The second step consists of software design for 3D printing or moul-
ding production in the case of standard implants and cutting guides. 
Step 3. Material Control: All manufacturing processes require high-quality materials that meet 
consistent specifications to build consistent, high-quality devices. This step is identical in both 
types of production of implants and guides. 
Step 4. Printing: When printing the implants or guides, different printers and materials are used 
depending on the material and the intended location. Different techniques are used as described 
below. In the case of standard devices, the mould is used to generate the implant guide using 
melted materials placed in the mould and hardened by different techniques, for example, freezing 
or using hardeners for some chemical substances. 
Step 5. Post-Processing: This step can also be the same in both standard and 3D printed devi-
ces. The design is tested and improved in terms of imperfections before being sterilised. 
Step 6. Validation and Verification: This step is also the same in both processes, and it requires 
tests of usability and adequacy for the purpose for which it was designed. 
Step 7. Testing: The two processes are again the same in this step. The processes in this step 
relate to the possible different requirements by regulation and the regulatory bodies in charge of 
certifying product safety and efficacy/performance (4,5)
6
.  
 
                                                     
6
  3D Print Exchange. National Institutes of Health; Available at: http://3dprint.nih.gov. Accessed July 12, 2018. 
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Figure 4.1: Process of 3D guide or prosthesis production. Modified from KCE, 2018 (3) 
 
 
Although the materials used (6-10) and the 3D printing techniques are diverse, and a number of 
them can be used for the indications in this assessment, we only describe those that have been 
found and analysed in the included studies. Detail about the products and materials used in the 
studies is low, so it has been difficult to define the type of printer and material (powder, resin, 
droplet, or extrusion) used in production. Each material requires a different type of 3D printer and 
defines the final product characteristics and performance. Powder materials are 3D printed by 
selective laser sintering (SLS), resins by stereolithography (SLA), extrusion materials by fused 
deposition modelling (FDM), and droplets by multi-jet modelling (MJM). For more details see Ap-
pendix 3. The materials used for implants and cutting guides in 3D printing are the same as those 
that are normally used for cutting guides and implants when produced by standards methods. 
Table 4.1 details the materials and indications for commonly used materials in clinical use.  
  
1.Device 
design 
2.Software 
design 
3.Material 
control 
4.Printing 
5.Post-
processing 
6.Validation 
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7.Testing 
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Table 4.1: Commonly used biomaterials in clinical use. Modified from Williams (11) 
Material Use 
Metals Titanium alloys Dental implants, femoral stems, pacemaker 
containers, heart valves, fracture plates, spinal 
cages 
Cobalt–chromium alloys  Bearing surfaces, heart valves, stents, pacemaker 
leads 
Platinum group alloys  Electrodes 
Nitinol (nickel and  
Titanium alloy) 
Shape memory applications 
Stainless steel  Stents, orthopaedic implants 
Magnesium and iron  Biodegradable metals for implants 
Bioceramics Alumina  Bearing surfaces 
Calcium phosphates  Bioactive surfaces, bone substitutes 
Carbon  Heart valves 
Zirconia Bearing surfaces 
Polymers Ultra-high molecular 
weight polyethylene  
Bearing surfaces 
PEEK Spinal cages, cranial  
PMMA Bone cement, intraocular lenses 
Polyurethane Pacemaker lead insulation 
Expanded PTFE Vascular grafts, heart valves 
Polyester textile Vascular grafts, heart valves 
Hydrogel Silicones  Soft tissue augmentation, insulating leads, 
ophthalmological devices 
Abbreviations: PEEK=polyether ether ketone; PMMA=poly(methyl methacrylate); PTFE=polytetrafluoroethylene 
The materials and comparators included in this assessment are listed in Table 4.2.  
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Table 4.2: Type of materials and comparators* included in this report (based on the evidence from the included articles) 
Product Indication Reference Material Type of printer Comparator 
Guides Maxillofacial Mazzoni 2013 Cobalt-chrome-molybdenum  Standard reconstruction with indirect CAD / computer 
aided manufacturing procedure 
 
Brandao 2016 Acrylic resin  Standard surgery Without guides 
Ayoub 2014 PolyMide Laser sintering Standard surgery Without guides 
Al-Ahmad 2013 Acrylic resin Zcorp Standard SSRO Without guides 
Cranial      
Knee Huijbregts 2016   Standard instrumentation Legion systems or Genesis 
II 
Boonen 2016   Standard instruments  
Pfitzer 2014   Standard instruments Journey 
Gan 2015 Acrylate resin Stereolithography Standard instruments Scorpio posterior stabilised 
system 
Qiu 2017   Standard instruments  
Zhang 2016  SPSS 350B solid laser 
prototyping 
Standard instruments Triathlon 
Thienpont 2017   Standard instruments  
Mannan 2016   Standard instruments  
Implants Cranial Chrzan 2012 Polypropylene-polyester or 
aluminium-silicon 
Milling Arrow 500 Standard instrumentation Manually adjusted 
prosthesis 
Knee      
Maxillofacial      
 * No further data were obtained from the articles on comparators 
Abbreviations: CAD=computer-aided design; SSRO=sagittal split ramus osteotomy 
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Regarding the manufacturers producing 3D printed implants and cutting guides in patients under-
going knee, maxillofacial, or cranial surgery, efforts were made to identify all relevant manufactu-
rers and their products. However, it is a diverse market, so the list may not be exhaustive. Only a 
few manufacturers responded to direct inquiries made by the assessment team to help identify 
relevant products.  
 
Table 4.3: Custom-made implants and custom-made surgical guides for cranio-maxillofacial surgery 
and orthopaedic traumatology surgery 
Manufacturer Relevant products Webpage 
Anatomics AnatomicsC3D: Custom im-
plants(cranial) 
http://www.anatomics.com/ 
Arcam EBM
®
 for Orthopaedic Implants http://www.arcam.com/solutions/ortho
pedic-implants/ 
Autodesk Within Medi-
cal 
Novax DMA 
CEIT-KE 
https://www.autodesk.com/products/wi
thin-medical/overview 
Avinent Personalised CAD/CAM im-
plants and prostheses 
https://www.avinent.com/eng/default.c
fm 
Bespokemedical   Bespoke solutions: 3D custom-made 
prostheses 
https://bespokemedical.com.au/ 
Zimmer Biomet  The Signature™ System https://www.zimmerbiomet.com.es/ 
CADskills BVBA CADCAMise: Anatomical mod-
els, cutting/drilling guides and 
3D print implants 
https://www.cadskills.be/en 
Cerhum SA Medical ceramic 3D printing https://www.cerhum.com/  
CUSMED No information found No information found 
EOS (3D printer pro-
ducer) 
3D printers for other manufac-
turers (e.g., Autodesk Within 
Medical) 
https://www.eos.info/en 
evonos GmbH & Co. Evo-Shape: Skull implants http://www.evonos.de/ 
Finceramica 
CustomBone: Custom-made implant 
for cranioplasty 
http://www.finceramica.it/ 
FIT Production FIT production: Custom-made 
implants 
http://www.fit-production.de/ 
Gsell Gsell Medical: Implants http://www.gsell.ch/en/home.html 
implantcast GmbH C-Fit 3D
®
: Patient-specific in-
struments and implants 
https://www.implantcast.de/ 
Johnson & Johnson 
Medical (DePuySyn-
thes) 
TruMatch
®
 cutting guides, for 
use with standard TKA (i.e., 
non-customised) implants 
(Sigma & Attune) 
 
https://www.depuysynthes.com/ 
Johnson & Johnson have contributed 
with input to the project plan, 2
nd
 draft 
assessment and by providing EU-
netHTA submission files.  
Kelyniam Global Inc. Kelyniam Implants: Cranial 
implants 
https://www.kelyniam.com/ 
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Manufacturer Relevant products Webpage 
KLS Martin Group 
 
IPS Implants
®
: Implants and 
implant systems for cranio-
maxillofacial surgery 
https://www.klsmartin.com/de/ 
LayerWise NV Metal additive manufacturing on 
demand 
https://lrd.kuleuven.be/en/spinoff/case
s/layerwise 
Materialise TruMatch CMF: Titanium 3D 
printed implant and patient-
specific cranio-maxillofacial 
implants 
https://www.materialise.com/en  
Materialise have contributed with input 
to the project plan, 2
nd
 draft 
assessment and by providing submis-
sion files. 
Mathys Orthopaedics  BalanSys and Affinis Architec http://www.mathysmedical.com/en/ho
mepage.html 
Medacta International 
SA 
MyKnee https://www.medacta .com/ 
MedCAD  AccuModel
®
 https://medcad.net/ 
Mimedis AG Mimedis
®
: Cutting guides and 
drill guides upon individual 
planning steps. 
http://www.mimedis.com/ 
Optimus 3D No customized products found https://optimus3d.es/ 
OssDsign AB OssDsign
®
 Cranial: CAD tech-
nology and 3D printing 
https://www.ossdsign.com/ 
OsteoSymbionics ClearShield
TM
: Craniofacial 
implants 
http://pdf.medicalexpo.com/pdf/osteos
ymbionics/osteosymbionics-
implants/90075-147775.html 
Raomed SA Custom-made implants and 
custom-made surgical guides 
for cranio-maxillofacial surgery 
and orthopaedic traumatology 
surgery 
http://www.raomed.com.ar/home 
Has contributed with input to the 2
nd
 
draft assessment.  
ResMed Narval https://www.resmed.com/epn/en/index
.html 
Smith & Nephew Visionaire: PMI total knee sys-
tem 
https://www.smith-
nephew.com/espana/ 
Stryker Corporation Triathlon Knee System https://www.stryker.com/ 
3DCERAM  3DCERAM custom-made or small 
series of bone substitutes skull im-
plants 
http://3dceram.com/ 
3D-Side 3D Model: Patient-specific anatomical 
model 
https://www.3dside.eu/en 
3D Systems 3D Systems Healthcare https://es.3dsystems.com/ 
Synimed Synicem ISM: Cranioplasty 
custom-made implants. 
http://www.synimed.com/ 
Tecres Cranos https://www.tecres.it/en/home 
Tissue Regeneration 
Systems inc. 
TRS (Tissue Regeneration 
Systems) technology 
https://www.tissuesys.com/ 
Xilloc Patient-specific implants and 
surgical guides 
https://www.xilloc.com/ 
4webmedical Osteotomy Truss System™ https://4webmedical.com/ 
Abbreviations: CAD=computer-aided design; CAM=computer-aided manufacturing; PMI=patient-modelled instrument; 
TKA=total knee arthroplasty 
Some manufactures have been identified in the later stage of the project, based on the suggestion of external experts. 
Therefore they were not consulted on the project plan.  
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After identifying the manufacturers and their products, two main issues needed clarifying: 1) which 
manufacturers made 3D printers for different purposes and with applications for medical purpo-
ses; and 2) which manufacturers used those 3D printers for medical purposes, especially those 
relevant to the scope of this report (6,7). Although this difference might be considered irrelevant, it 
is, however, relevant from the safety and legal points of view, i.e., whether the manufacturer is 
simply selling 3D printers for different purposes which can be used for medical purposes or if they 
are also involved in the design and production of medical devices. In fact, some manufacturers do 
either or both. 
Table 4.4 shows the manufacturers, their products, and their characteristics. Most manufacturers 
did not directly provide information despite several attempts to make contact. Therefore, the ana-
lysis presented in Table 4.4 is based on publicly available information obtained from manufactu-
rers' webpages, brochures, and elsewhere. The information is not to be considered exhaustive 
and might contain inaccuracies. 
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Table 4.4: Custom-made or customisable 3D printed implants and cutting guides in patients undergoing knee, maxillofacial, or cranial surgery. Shown are the  
manufacturers, products, locations, type of products and materials used 
  Relevant products 
Anatomical 
location 
Guide Prosthesis Material 1 Material 2 Material 3 
 3D Ceram Cranial  X Ceramics     
  Maxillofacial  X Ceramics     
3D-Side SkullPT Cranial  X Bone cement     
Adaptive SkullPT Cranial   Bone cement     
Anatomics Durashield Cranial  X Silicone   
Biomodel Stereotaxy Cranial X     
  Cranial  X Acrylic (polymethyl metha-
crylate) 
Porestar (porous poly-
ethylene) 
Titanium 
  Facial  X  Porestar (porous poly-
ethylene) 
Titanium 
Biomodels   X      
Mandible templates & guides Facial X X    
Cranial templates Cranial X X    
Bespokemedical    Knee  X    
Zimmer Biomet  Persona
®
; Vanguard; NexGen Knee  X Bearing materials: Vivacit-E 
vitamin E highly crosslinked 
polyethylene; E1
®
 antioxidant-
infused polyethylene; Pro-
long
®
 highly crosslinked 
polyethylene; Durasul
®
 highly 
crosslinked polyethylene 
OsseoTi
®
 Porous Metal 
Technology 
 
Encompass
TM
, Midface Maxillofacial X X PEEK Polymer Titanium 
HTR PEEK, HTR PMMA, Cranio-
curve
®
, ThinFlap
TM
, SterileTrac
TM
, 
RapidFire
®
 
Cranial X X Idem Idem Idem 
CADskills BVBA   Cranial X X Titanium, PEEK CADskills has developed 
a new UHMWPE specifi-
cally treated to increase 
wear resistance. The 
method is undisclosed. 
The UHMWPE is en-
riched with vitamin E, a 
potent antioxidant. These 
characteristics make this 
Cutting guides are 
3D printed in a 
class 1 bio-
compatible resin 
that is autoclava-
ble. The material 
is specially devel-
oped for printing 
precise surgical 
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  Relevant products 
Anatomical 
location 
Guide Prosthesis Material 1 Material 2 Material 3 
material especially suited 
for articulating surfaces 
guides and similar 
devices 
  Maxillofacial X X Idem Idem Idem 
Cerhum SA (for confi-
dentiality reasons, final 
product not disclose) 
  Maxillofacial  X Alumina Zirconia   
  Cranial  X       
  Knee  X      
Evonos   Cranial  X Titanium     
Finceramica  Customized Bone (USA only) / 
CustomBone 
Cranial  X Biomimetic ceramic     
Fit-production  
(Does not specify the 
type of implants) 
  Cranial  X Titanium (EBM technology)     
  Maxillofacial  X       
  Knee  X      
Gsell   Knee  X UHMWPE (Ultra high molecu-
lar weight polyethylene), 
PEEK, PEKK, CF, pyrolytic 
graphite 
    
Implantcast   Knee  X Implavit: The majority of 
implants are made of a cobalt 
chrome molybdenum 
(CoCrMo)  
Implatan: The raw titani-
um (TiAl6V4) alloy mate-
rial  
UHMWPE 
Johnson & Johnson 
Medical (DePuySyn-
thes) 
TruMatch
®
 cutting guides, for 
use with standard TKA (i.e., 
non-customised) implants 
(Sigma & Attune) 
Knee X       
Kelyniam   Cranial, cranio-
facial 
 X PEEK, lightweight Bio-
material  
    
KLS Martin   Cranial  X Titanium Resorbable materials   
  Maxillofacial  X       
Materialise (Johnson & 
Johnson) 
TruMatch
®
 Cranio-
maxillofacial  
X X Titanium and polyamide 
(guides) 
    
TruMatch
®
 Cranial X X Titanium and polyamide 
(guides) 
  
  Knee X   Polyamide     
Mathys Orthopaedics 
Ltd. 
BalanSys Knee  X      
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  Relevant products 
Anatomical 
location 
Guide Prosthesis Material 1 Material 2 Material 3 
Medacta International 
SA 
GMK Knee X X Cobalt-chrome UHMWPE   
MedCAD  AccuShape
®
 Cranial  X PEEK     
  Craniofacial X       
Mimedis (Medartis)   Craniofacial  X Flexible     
OssDSIGN   Craniofacial  X Titanium     
Osteosymbionics ST-temporalis, PK-Shield Craniofacial  X      
Raomed   Cranial X X Titanium  PEEK PMMA, polyamide 
  Maxillofacial X X Titanium PEEK Cr-Co-Mo, 
UHMWPE, 
PMMA, polyamide 
Stryker Corporation   Cranial  X MEDPOR and PEEK Titanium   
    Maxillofacial X X MEDPOR and PEEK Titanium   
    Knee  X Titanium     
Synimed Synicem ISM Craniofacial   Cements     
Tecres Cranos Cranial  X Polymethylmethacrylate     
Tissue Regeneration 
Systems  
TRS Scaffold Technology Cranio-
maxillofacial  
 X    
Xilloc  Cranio-
maxillofacial 
 X PEEK-OPTIMA
®
: polymeric 
biomaterial  
TI6Al4V: Titanium alloy PP/PES knitted 
yarn: polymeric 
knitted from yarn 
4WEB Medical  Craniofacial X   Polyamide Metallic   
Abbreviations: EBM=electron beam melting; PEEK=polyether ether ketone; PES=polyester; PMMA=poly(methyl methacrylate); PP=polypropylene; TKA=total knee arthroplasty; UHMWPE=ultra-
high molecular weight polyethylene; X=available information  about  guide or prosthesis; Empty space=no information. 
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[B0002] – What is the claimed benefit of 3D printed implants and cutting guides compared 
to standard implants and cutting guides? 
The claimed benefit of the technology in relation to the comparator(s) is the personalisation and 
the customisation of cutting guides and implants and the possibility of “in-house” producing 3D 
printed solutions (12,13,14). Based on this personalisation and customisation, the manufacturers 
claim that safety, performance, and efficacy are improved compared with standard practice inclu-
ding the use of customisable implants. Some manufacturers have also claimed that in the case of 
certain guides and implants, especially maxillofacial and cranial implants in which standardisation 
is more complicated or costly, 3D printers could be a viable economic solution for single implants 
or cutting guides.  
[B0003] – What is the phase of development and implementation of 3D printed implants 
and cutting guides?  
3D printing technology is not yet fully or widely implemented, and the comparator is standard 
practice. Some commercialised solutions such as TruMatch
®
 from Johnson & Johnson and Tru-
Match
®
 CMF from Materialise have received US Food and Drug Administration (FDA) clearance 
through the 510(k) procedure (see Table 4.3). However, in most cases, 3D printing technology 
has been introduced as a research or innovative technology without clear moderate or high-level 
clinical evidence on its effects, and should therefore be considered under research premises. The 
comparator in the included studies is not always well described, making it difficult to describe the 
standard solutions in detail. 
[B0004] – Who administers 3D printed implants and cutting guides and standard implants 
and cutting guides and in what context and level of care are they provided? 
In general, the comparators and 3D printing technology are administered at the tertiary level of 
provision. This is not due to production requirements, rather the necessary implementation of the 
comparators in those premises or under this frame of provision (15). The use of standard implants 
and cutting guides requires skilled professionals and learning curves that guarantee quality im-
plementation of the technology. Similarly, 3D printed implants and cutting guides are administered 
by certified professionals in accredited centres to ensure high quality provision of care, although 
the level of certification differs from country to country and in some countries any centre can pro-
vide the service and use the technology. The same level of expertise is required in those centres 
implementing or researching 3D printing solutions as those using standard implants or cutting 
guides. In cases where no regulatory approval of 3D printed solutions is needed, the use of 3D 
printed solutions is considered under research circumstances and thus details of the technology 
must be communicated to the patient and his/her caregiver as required as part of informed con-
sent. 
[B0008] – What kind of special premises are needed to use 3D printed implants and cutting 
guides and standard implants and cutting guides? 
No special premises are required for the use of custom-made 3D printed devices compared to 
standard implants and cutting guides. The main differences are related to device production and 
not to their application and use in clinical practice.  
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[B0009] – What equipment and supplies are needed to use 3D printed implants and cutting 
guides and standard implants and cutting guides? 
The equipment needed for using 3D printed devices is dependent on the organisation of the entire 
production process and how much of this production is in-house. The main equipment required for 
the 3D printing process is imaging processing systems and 3D printers. If the organisation is 
simply contracting production from external manufacturer, the equipment needed is similar to the 
equipment required to use standard implants and cutting guides.  
[A0020] – For which indications have 3D printed implants and cutting guides received mar-
keting authorisation (FDA or CE marking)? 
Here it is necessary to differentiate between 3D printing market authorisation and CE marking of 
the final products/devices. 3D printers in themselves are not normally considered a medical de-
vice and receive CE marks as other technologies on the market. In the case of implants and cut-
ting guides, it is unclear what authorisation is required, since the implants and cutting guides 
could be classified as custom-made or customisable. As all the devices in this assessment could 
be considered custom-made, the issue is that even as class III devices they do not need to bear 
the CE mark because they are custom-made. This does not, however, mean that they are not 
subject to regulatory control through post-market surveillance via competent authorities of the 
member states, where manufacturers are required to report incidents and maintain post-market 
surveillance.  
However, some manufacturers, for example Johnson & Johnson and Materialise, have received 
CE or FDA authorisation, but the performance at the individual implant/cutting guide level still 
needs to be evaluated to establish the technology’s value. So, the consideration of custom-made 
or customisable must be taken into account and their differentiation, when 3D printed, is not well 
defined. Until there is conclusive evidence of safety and efficacy, patients should be informed of 
the alternatives and the uncertainties of their use, with data being collected. Procedures such as 
those proposed by EUnetHTA JA3, WP5 for data collection post introduction should be followed 
to ensure data quality in those registries. 
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5   HEALTH PROBLEM AND CURRENT USE OF THE TECHNOLOGY (CUR) 
5.1 Research questions 
Element ID Research question 
A0002 
Which diseases or health conditions most frequently lead to knee, maxillofacial, or cranial 
surgery? 
A0004 What is the natural course of the disease or health condition? 
A0005 What are the symptoms and the burden of disease or health condition for the patient? 
A0006 What are the consequences of the disease or health condition for society? 
A0024 
How is the disease or health condition currently diagnosed according to published 
guidelines and in practice? 
A0025 
How is the disease or health condition currently managed according to published 
guidelines and in practice? 
A0007 What is the target population in this assessment? 
A0023 How many people belong to the target population? 
A0011 How much are the technologies utilised? 
 
5.2   Results 
3D printed medical devices are used in a wide variety of indications. This assessment focuses on 
the following clinical areas in which 3D printed custom-made or customisable implants and cutting 
guides are most frequently applied and where most of the published evidence lies: knee, 
maxillofacial, and cranial surgery. The most frequent diseases in these clinical areas include knee 
osteoarthritis treated with total knee arthroplasty, oral cancer treated with mandibular 
reconstruction, and traumatic brain injury with intracranial hypertension treated with 
decompressive craniectomy (DC) and later cranioplasty (3, 16). 
 
Overview of the diseases or health conditions 
[A0002] – Which diseases or health conditions most frequently lead to knee, maxillofacial, 
or cranial surgery? 
Knee osteoarthritis 
The primary indication for total knee arthroplasty (TKA) is the relief of significant and disabling 
pain and improvement of functional status in patients with end-stage knee osteoarthritis (OA) (17). 
Two types of knee OA are recognised: primary knee OA is caused by progressive joint cartilage 
destruction over time without any apparent underlying cause, while secondary OA can be caused 
by trauma or surgery to the joint structures, congenital limb malformations, malposition (va-
rus/valgus), or abnormal articular cartilage such as that found in end-stage rheumatoid arthritis 
(RA) (18).  
Oral cancer 
Invasive oral cancer is the primary indication for mandibular reconstruction, but it is also used for 
other diseases such as osteomyelitis and bisphosphonate-related osteonecrosis (19). Oral cancer 
includes a group of neoplasms affecting any region of the oral cavity, pharyngeal regions, and 
salivary glands. Oral squamous cell carcinoma (OSCC) is the most frequent (90%) oral neoplasm.  
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Traumatic brain injury 
Cranial surgery with cranioplasty after decompressive craniectomy (DC) is widely used to treat 
intracranial hypertension (ICH) following traumatic brain injury (TBI), stroke, and other conditions 
associated with raised intracranial pressure (20).  
[A0004] – What is the natural course of the disease or health condition? 
Knee osteoarthritis 
Knee OA is characterised by progressive destruction of the cartilage that lines the knee joints, the 
subchondral bone surfaces, and synovium. It is accompanied by pain, immobility, muscle weak-
ness, and reduced function and activities of daily living (21). Knee OA is chronic and progressive 
and worsens over time with pain as the primary symptom. It starts with intermittent weight-bearing 
pain and develops to more persistent pain, especially if contributing factors (obesity, misalign-
ment, and occupation) are not properly modified. Without treatment, OA eventually leads to signi-
ficant pain and disability requiring surgical intervention (22). Knee RA is a chronic inflammatory 
disease characterised by synovial hyperplasia, bone loss, and joint deformity, which eventually 
leads to pain and disability requiring surgical intervention (23). 
Oral cancer 
Oral squamous cell carcinoma (OSCC) often presents as an ulcer with fissuring or raised margins 
or may present as a lump, a red, white or mixed white-red lesion, a non-healing wound, or with 
cervical lymph node enlargement (23). Despite advances in therapeutic approaches, OSCC prog-
nosis is poor due to frequent aggressive local invasion, metastasis, and recurrence. The five-year 
survival rate ranges from 20-90% depending on which part of the oral cavity is involved and the 
stage. Patients diagnosed early have a better long-term survival (60-90%), whereas when diag-
nosis is late the long-term survival ranges from 20-50% (24). 
Traumatic brain injury 
TBI describes an injury to the head arising from blunt or penetrating trauma or accelera-
tion/deceleration forces. It is associated with one or more of the following features: decreased 
level of consciousness, amnesia, objective neurological abnormalities, and skull fractures (25). 
The Glasgow Coma Scale (GCS) is used to triage patients early after TBI as an indicator of sever-
ity, with TBI graded as mild, moderate, or severe (25). After primary brain injury, there is a risk of 
secondary injury from intracranial hypertension (ICH) as a consequence of brain swelling or 
haemorrhage. ICH is the most frequent cause of death and disability following severe TBI (25) 
and is often treated with DC and later cranioplasty. 
 
Effects of the disease or health condition 
[A0005] – What are the symptoms and the burden of disease or health condition  
for the patient? 
Knee osteoarthritis 
For the individual, the burden of knee OA includes pain, limited activity, and markedly reduced 
quality of life. The intensity of clinical symptoms and rate of progression vary greatly from person 
to person. However, symptoms typically become more frequent and severe and cause progres-
sive limitations in function over time, eventually leading to disability. Patients experience knee 
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pain that is gradual in onset and that worsens with activity, swelling and knee stiffness, and pain 
after prolonged sitting or resting (18). In a population in New Zealanders aged 40-84 years, knee 
OA accounted for 3.44 quality-adjusted life years (QALYs) lost per person, corresponding to 
467,240 QALYs across the population. These QALY losses were higher for females than males 
due to a greater prevalence of knee OA and higher life expectancy (26). 
Oral cancer 
The initial stages are often painless. In later and larger lesions, symptoms vary from mild discom-
fort to severe pain. Other symptoms include ear pain, bleeding, mobile teeth, breathing problems, 
speech difficulties, dysphagia, problems using prostheses, trismus, and paraesthesia (27). Many 
oral cancer patients suffer from anxiety and depression which negatively impact their quality of 
life, and the suicide incidence is high in this patient group (28).  
Traumatic brain injury 
After TBI of any severity, many patients display cognitive and emotional difficulties and require 
assistance in their activities of daily living (25,29). Reduced health-related quality of life (HRQoL) 
has been identified in individuals with TBI compared with a healthy population (30). 
[A0006] – What are the consequences of the disease or health condition for society? 
Knee osteoarthritis 
The knee is the most frequently affected joint in OA, and the societal and economic burden of this 
disease at a population level is substantial. Most of the direct costs are usually attributed to the 
healthcare system including hospital stays, orthopaedic surgery, medications, doctor visits, and 
other health professional visits. Indirect costs are also incurred that are attributable to productivity 
losses from absenteeism, presenteeism, early retirement, and premature death (31).  
Oral cancer 
Oral cancer is a significant public health concern. According to global estimates, oral cancer 
causes approximately 130,000 deaths per year (32). There is a heavy financial burden to society 
in treating oral cancer that includes direct costs for diagnosis, treatment, and hospitalisation and 
indirect costs including loss of productivity due to morbidity and disability (33). 
Traumatic brain injury 
TBI is a major public health problem worldwide and is the most common cause of death and disa-
bility in children and young adults. Over 50% of patients with severe TBI are moderate to severely 
disabled after one year, and many never recover to full independence (33). The costs for treating 
severe TBI result in a heavy financial burden to society, where the indirect costs of disability, lost 
wages, and lost productivity outweigh the direct medical costs including hospitalisation and reha-
bilitation (34). 
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Current clinical management of the disease or health condition 
[A0024] – How is the disease or health condition currently diagnosed according to pub-
lished guidelines and in practice? 
Knee osteoarthritis 
The diagnosis of knee OA can usually be made by clinical judgment and imaging performed by 
clinical experts, but these are not the only markers of knee OA. The European League Against 
Rheumatism (EULAR) has developed evidence-based recommendations for the diagnosis of 
knee OA (34). These include typical symptoms and signs, the use of imaging and laboratory tests, 
and differential diagnosis. Three symptoms (persistent knee pain, limited morning stiffness, and 
reduced function) and three signs (crepitus, restricted movement, and bony enlargement) were 
found to be most useful. The severity of knee OA can be staged using the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC), which reflects clinical symptoms divided 
into three subscales: pain, stiffness, and physical function (35). 
Oral cancer 
The diagnosis of OSCC is based on a thorough clinical examination of the oral mucosa and pal-
pation of the lymphoid tissue of the neck to detect masses that represent metastases. The clinical 
findings should be verified with a biopsy to confirm the diagnosis histopathologically (27). The 
tumour-node-metastasis (TNM) classification is used to stage oral cancers (36). 
Traumatic brain injury 
There is no consensus on definitive diagnostic measures, but there is general agreement that a 
clear mechanism and suspicion of injury plus a minimum of one common clinical feature define a 
TBI. The diagnosis is based on injury history, clinical examination including GCS, and CT scans of 
the head (37). 
[A0025] – How is the disease or health condition currently managed according to 
published guidelines and in practice? 
Knee osteoarthritis 
Knee OA is not currently curable, and the goal of non-operative treatment is to alleviate the signs 
and symptoms of the disease and to slow its progression. Conservative treatment is generally 
indicated in patients with generalised knee pain who wish to delay undergoing a surgical proce-
dure. According to EULAR recommendations, conservative treatment of knee OA should proceed 
in a stepwise fashion including physical and physiotherapeutic measures, orthopaedic aids, 
weight loss, and drug therapy (34). Despite conservative treatment, many with severe knee OA 
require a TKA as the definitive treatment (35). 
Oral cancer 
The treatment of OSCC consists of surgery, radiotherapy, and chemotherapy. OSCC is typically 
treated by one or a combination of these modalities according to tumour location and stage (38).  
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Traumatic brain injury 
DC is used as a therapeutic strategy for refractory cerebral oedema in cases when first-line non-
invasive methods fail (29). Cranioplasty is then performed not only for aesthetic reasons but also 
to protect the underlying neural tissue and improve its perfusion and metabolism (39). 
 
Target population 
[A0007] – What is the target population of this assessment? 
Knee osteoarthritis 
The incidence and prevalence of knee OA have increased over recent decades at least in part 
due to an aging population and the rising prevalence of obesity (40). Knee OA affects at least 
19% of adults aged 45 years, and >50% of patients over 65 years have radiographic changes in 
the knee indicating arthritis, although many patients are asymptomatic until after age 65 years 
(41,42). Moreover, the occurrence of knee OA in younger active people is reported to be increa-
sing (40). The global prevalence of radiographically conﬁrmed symptomatic knee OA in 2010 was 
estimated to be 3.8% (40). 
Oral cancer 
OSCC is most common in older males with a history of tobacco and alcohol consumption, in lower 
socio-economic groups, and in ethnic minority groups (36). However, some studies have shown a 
high frequency of OSCC in younger adults (aged <40 years), probably due to changes in lifestyle 
habits in this age group such as changes in tobacco and alcohol consumption as well as exposure 
to biological agents such as human papillomavirus (HPV) (43).  
Traumatic brain injury 
TBI is most common in children and young adults (25). 
[A0023] – How many people belong to the target population? 
Knee osteoarthritis 
In Denmark, which has approximately 5.5 million inhabitants, 60,000 people each year with symp-
toms of knee arthritis seek medical advice
7
. In the USA, knee OA accounts for over 80% of all OA 
and affects at least 19% of adults aged 45 years and older (42). The number of people in the tar-
get population with symptomatic OA is likely to increase due to the aging population and the rise 
in the prevalence of obesity (44).  
Oral cancer 
Worldwide, oral cancer accounts for 2-4% of all cancer cases, corresponding to 300,000 new 
cases diagnosed in 2012 (45). Age-standardised oral cancer incidence rates vary between 0.9 per 
100,000 women in Eastern Asia to 24.0 per 100,000 men in Melanesia. 
                                                     
7
 [www.sst.dk/da/udgivelser/2012/nkr-og-faglige-visitationslinjer-knaeartrose] 
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Traumatic brain injury 
It is estimated that TBI affects over 10 million people annually worldwide, leading to either mortali-
ty or hospitalisation (46). 
[A0011] – How much are the technologies utilised? 
Knee osteoarthritis 
The total number of primary and revision TKAs in Europe was estimated to be 1,324,000 each 
year in 2011, whereas the number of patient-specific instrument (PSI) procedures was 17,515, 
corresponding to 1.3% of total (1,2). 
Oral cancer 
The mandibular reconstruction with free fibula flap is currently regarded as the gold standard re-
construction of large segmental mandibular defects caused by benign or malignant disease (47). 
Mandibular reconstruction has changed significantly over the years and continues to evolve with 
the introduction of newer technologies and techniques. 3D printing is a rapidly growing technology 
in medicine, and when mandibular reconstruction is performed with a fibula free flap with 3D 
printed models, the long bone can be reconfigured into a 3D angular structure (48). There are no 
available published data on the utilisation of these technologies in Europe. 
Traumatic brain injury 
There are no available published data on the utilisation of either standard cranioplasty or with 3D 
printed materials.  
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6   CLINICAL EFFECTIVENESS (EFF) 
6.1   Research questions 
Element ID Research question 
D0001 What is the expected benefit of 3D printed implants and cutting guides on mortality? 
D0005 
How does use of 3D printed implants and cutting guides affect symptoms and findings 
(severity, frequency) of patients undergoing surgery? 
D0006 
How do 3D printed implants and cutting guides affect progression (or recurrence) of the 
disease or health condition? 
D0011 What is the effect of 3D printed implants and cutting guides on patients’ body functions? 
D0016 How does the use of 3D printed implants and cutting guides affect activities of daily living? 
D0012 
What is the effect of 3D printed implants and cutting guides on generic health-related 
quality of life? 
D0013 
What is the effect of 3D printed implants and cutting guides on disease-specific quality of 
life? 
D0017 Were patients satisfied with the use of 3D printed implants and cutting guides? 
 
6.2   Results 
Included studies 
Thirteen studies reported clinical effectiveness outcomes (19,39,49-59). Eight studies (six RCTs 
(49-54) and two SRs (55,56) reported on patients undergoing knee reconstruction; four studies 
(three RCTs (19,58,59) and one prospective study (57) reported on maxillofacial patients (more 
specifically patients undergoing mandibular reconstruction); and one prospective study examined 
patients undergoing cranioplasty (39). Details of the studies are provided in Table A1 and Table 
A2. Studies published between 2012 and 2017 had follow-up periods of between one and 44 
months.  
Results are presented according to the research questions categorised in relation to specific out-
comes and finally patient group. Not all patient groups are represented under a specific outcome, 
since some outcomes relate to particular patient groups, e.g., the outcome 'number of outliers' 
only includes results from knee arthroplasty patients.  
The quality of the two included cohort studies by Chrzan et al. (39) and Mazzoni et al. (57) was 
low. However, the quality of the two SRs by Thienpont et al. (55) and Mannan et al. (55,56) was 
high. Studies included in the two SRs were of moderate to high quality. The quality of the included 
RCTs was in general moderate, although one study by Qui et al. (53) was low quality. Blinding 
was the criterion most often described unevenly. Reporting of the blinding status of study partici-
pants, personnel, and assessors was in general incomplete, making the risk of bias unclear. Ta-
bles 6.1 and 6.2 present the risk of bias of the RCTs and SRs. 
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Table 6.1: ROBIS results on selected systematic reviews 
Review Phase 2 Phase 3 
 1. STUDY 
ELIGIBILITY 
CRITERIA 
 2. IDENTIFICATION 
AND SELECTION 
OF STUDIES 
 3. DATA COL-
LECTION AND 
STUDY APPRAIS-
AL 
4. SYNTHESIS 
AND FINDINGS 
RISK OF BIAS IN 
THE REVIEW 
Thienpont           
 Mannan           
 
 
Table 6.2: Cochrane risk of bias results on RCTs 
 
 
 
 
Mortality 
[D0001] What is the expected benefit of 3D printed implants and cutting guides on 
mortality? 
Mortality was not specified as an outcome in any study and was not reported in any of the inclu-
ded RCTs or cohort studies. 
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Morbidity 
[D0005] – How does use of 3D printed implants and cutting guides affect symptoms and 
findings (severity, frequency) of the patients undergoing surgery?  
[D0006] – How do 3D printed implants and cutting guides affect progression (or 
recurrence) of the disease or health condition? 
Number of outliers (by >3°) in TKA: 3D print vs. standard implants and cutting guides in patients 
undergoing knee reconstruction  
Hip-knee-ankle angle (limb), alignment, or mechanical axis (Figure 6.1) 
The number of outliers in TKA was reported in four RCTs (49,51-53) and one SR (55). Data from 
all four primary studies were included in the meta-analysis. The odds ratio calculated using the 
number of events in the two groups was 0.28 (95% CI 0.12-0.66; p=0.003) favouring 3D print 
technology (cutting guides; low quality of evidence). There was a low degree of heterogeneity 
between the studies (I
2
=33%, p=0.21) (Figure 6.2). 
The SR by Thienpont et al. (55) reported a pooled relative risk of 0.79 (95% CI 0.65-0.95; 
p=0.013) favouring PSI/3D print technology. Mechanical axis deviation (by >3°) was the primary 
endpoint in the SR, which included 44 RCTs and cohort studies. 
 
Figure 6.1. Hip-knee-ankle angle, mechanical axis, coronal femoral angle, and coronal tibial angle. 
Source: Jan Hejle, anatomi.dk 
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Figure 6.2: 3D print vs. standard; outcome: proportion of outliers (>3°), hip-knee-ankle angle 
 
Coronal femoral angle 
Coronal femoral angle, which describes implant alignment measured between the mechanical 
femoral axis and the tangent of the distal femoral condyles (51) (Figure 6.1), was assessed in four 
RCTs (49,51-53) and one SR (55). The odds ratio was statistically significant at 0.24 (95% CI 
0.09-0.68; p=0.007) and favoured 3D print technology (low quality of evidence). There was a low 
degree of heterogeneity between studies (I
2
=32%, p=0.22) (Figure 6.3). The SR by Thienpont et 
al. (55) reported a relative risk of 0.74 (95% CI 0.55-0.99; p=0.043) in favour of PSI/3D print tech-
nology. 
 
Figure 6.3: 3D print vs. standard; outcome: proportion of outliers (>3°), coronal femur 
 
Coronal tibial angle 
The coronal tibial angle, which describes the angle between the mechanical tibial axis and the 
tangent at the implant-bone interface of the tibia (51) (Figure 6.1), was assessed in four RCTs 
(49,51-53) and one SR (55). The odds ratio was statistically significant at 0.29 (95% CI 0.12-0.69; 
p=0.005) and favoured 3D print technology (low quality of evidence). There was no heterogeneity 
between studies (I
2
=0%, p=0.40) (Figure 6.4). Thienpont et al. (55) reported an insignificant rela-
tive risk of 1.30 (95% CI 0.92-1.83; p=0.13). 
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Figure 6.4: 3D print vs. standard; outcome: proportion of outliers (>3°), coronal tibial angle 
 
Tibial slope 
The tibial slope or sagittal tibial alignment is defined as the angle between the anterior tibial cortex 
and the tangent of the implant’s inferior surface (Figure 6.5) (51). It was assessed in three RCTs 
(49,51,53) and one SR (55). As with the coronal alignment outliers, the tibial slope outlier was 
defined as deviation of >3° from the planned alignment, which is normally intended to be a poste-
rior slope of 3°. The analysis showed inconsistent results, and the odds ratio was not statistically 
significant at 0.55 (95% CI 0.07-4.43; p=0.57) (very low quality of evidence). Also, there was high 
heterogeneity between studies (I
2
=86%, p<0.001) (Figure 6.6). However, the point estimate of 
0.55 was found to be robust based on the fixed effects analysis, which showed a point estimate of 
0.91, well within the confidence interval of the random effects analysis. The SR by Thienpont et al. 
(55) reported a relative risk of 1.32 (95% CI 1.12-1.56; p=0.001) in favour of standard surgery. 
 
Figure 6.5: Tibial slope angle. Source: Jan Hejle, anatomi.dk 
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Figure 6.6: 3D print vs. standard; outcome: proportion of outliers (>3°), tibial slope  
 
Femoral rotation 
Rotation of the femoral component can be defined as the angle between the posterior condylar 
line and the epicondylar axis (Figure 6.7) (49). This was measured in two RCTs (49,51) and one 
SR (55). The analysis showed an insignificant odds ratio of 0.33 (95% CI 0.07-1.56; p=0.16; low 
quality of evidence) with a tendency favouring 3D printing. High heterogeneity was present be-
tween the studies (I
2
=73%, p=0.05), but the result was robust (Figure 6.8). Thienpont et al. (55) 
also found no difference between groups, reporting a relative risk of 0.97 (95% CI 0.69-1.38; 
p=0.88). 
 
Figure 6.7: Femoral rotational angle. Source: Jan Hejle, anatomi.dk 
 
 
 
Figure 6.8: 3D print vs. standard; outcome: proportion of outliers (>3°), femoral rotation 
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Absolute deviation in degrees (hip-knee-ankle angle): 3D print vs. standard implants and cutting 
guides in patients undergoing knee reconstruction  
Absolute deviation in degrees was reported in five studies (49,51-54). Two studies reported hip-
knee-ankle angle as mean values (49,53). The meta-analysis showed a small and statistically 
insignificant pooled estimate of -1.28° (95% CI -3.29-0.74; p<0.0001) in support of 3D print tech-
nology (very low quality of evidence). There was a high degree of heterogeneity between studies 
(I
2
=95%, p<0.0001), but the result was robust (Figure 6.9). Gan et al. (52) found a significant dif-
ference of 4° in the mechanical limb axis in support of the 3D print group (navigational template) 
compared to standard, but no standard deviation was reported (52). Pfitzner et al. (51) found a 
significant difference of 1.5° and 3.5° in the CT-based and MR-based patient-specific instrumenta-
tion groups (3D print), respectively, compared to standard surgery (51). 
 
Figure 6.9: 3D print vs. standard; outcome: absolute deviation in degrees, hip-knee-ankle angle 
 
Regarding other alignment assessments, most studies reported absolute deviations in the coronal 
femoral component, coronal tibial component, and tibial slope component. The absolute deviation 
in the coronal femoral component in all five studies (51,53,54) was reported to be significantly and 
consistently smaller in the 3D print groups than in standard groups, although median/mean diffe-
rences were minor (0.3°-2.0°) between groups. The absolute deviation in the coronal tibial com-
ponent in four studies (51-54) was significantly smaller in the 3D print groups than in standard 
groups, with median/mean differences of 1.0°-2.0° between groups. Huijbrechts et al. (49) found 
no difference between the groups.    
The posterior tibial slope component was reported in five studies (49,51-54). In three studies 
(49,52,53), the absolute deviation was found significantly higher in the 3D print groups than in the 
standard groups, with differences of 0.1°-1.7°. In two studies, deviation in the tibial slope compo-
nent was significantly smaller (2.5°-4.1°) in favour of the 3D print groups (51,54). 
Operating time: 3D print vs. standard implants and cutting guides in patients undergoing knee 
reconstruction   
Operating time was measured and reported in four RCTs (49,51,52,54) and one SR (55). 
Huijbrechts et al. (60) reported that reduced operating time may increase surgical efficiency and 
potentially reduce surgical complications. Pooled results from three studies showed a significant 
estimate of 9.47 minutes shorter operating time favouring 3D print technology (95% CI 0.84-18.1; 
p=0.03; low quality of evidence) (Figure 6.10). There was a high degree of heterogeneity between 
studies (I
2
=94%, p<0.0001); however, the analysis found the result to be robust. In the study by 
Zhang et al. (54), operating time in the 3D print group was 10.7 minutes shorter than in the stand-
ard group (p<0.01). A minor significant difference of 4.4 minutes (95% CI 1.7-7.2) in favour of 3D 
print technology was also found in the SR by Thienpont et al. (55). 
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Figure 6.10: 3D print vs. standard; outcome: operating time, patients undergoing knee reconstruction 
 
 
3D print vs. usual care in maxillofacial surgery patients  
Operating time was assessed in one randomised study of four studies evaluating computer-
assisted mandibular reconstruction (19). Operating time was the main outcome. The operating 
time was presented in terms of six outcomes: a) shaping time at the donor site, significant diffe-
rence in favour of standard group, 37.8 min vs. 62.1 min; b) shaping time at the defect site, signi-
ficant difference in favour of 3D print group, 6.2 min vs. 20.3 min; c) time for osteosynthesis, sig-
nificant difference in favour of 3D print group, 10.1 min vs. 18.2 min; d) overall reconstruction time 
(which includes time to shape the transplant and perform the osteosynthesis), significant diffe-
rence in favour of 3D print group, 16.4 min vs. 38.5 min (p<0.001); e) ischaemic time (time from 
dissection of the transplant until perfusion is restored), significant difference in favour of 3D print 
group, 96.1 min vs. 122.9 min (p<0.005); and f) overall operating time, no difference between the 
groups, 498.5 min vs. 525.2 min (p=0.527). Further, no difference was found in ICU time and 
postoperative hospitalisation time. 
3D print vs. usual care in cranioplasty patients  
Using 3D print imaging and print technology reduced the time of cranioplasty neurosurgery by 
16.2 minutes (p<0.001) in a group of 19 patients compared to a control group of 20 patients (very 
low quality of evidence) (39). 
Visual analogue scale (VAS) 
One study reported pain one and two years postoperatively in patient undergoing TKA and found 
no difference between 3D print and standard groups (p=0.227) (50). 
Blood Loss 
Blood loss or blood transfusion was assessed in two RCTs (52,54) and one SR (55) on patients 
undergoing knee reconstruction and in one RCT of maxillofacial surgery patients (19). In two stu-
dies (19,54), there was no difference in blood loss between the groups, and in two other studies 
(52,55), there was a significant difference in blood loss in favour of the 3D print groups, with a 
mean difference of 38 and 90 ml, respectively. Although significant, these differences were of no 
clinically relevant value. 
Precision 
Precision or accuracy was evaluated in one small prospective study of low quality in patients un-
dergoing mandibular reconstruction (57). The study results can only be indicative of the effect of 
3D printing technology in this area. Mazzoni et al. (57) found no difference between groups in 
patients undergoing prosthetically guided mandibular reconstruction with respect to midline devia-
tion (vertical and horizontal), mandible angle-shift right, angular deviation of the mandibular arch, 
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and condyle position left. Significant differences in favour of the 3D intervention were reported for 
the outcomes mandible angle-shift left (mean 1.4 mm vs. 5.042 mm; p<0.006) and condyle posi-
tion right (mean 1.297 mm vs. 4.458 mm; p=0.035). 
Changes in sensory function 
Changes in sensory function were evaluated in only one small RCT of moderate quality in patients 
undergoing bilateral sagittal split ramus osteotomy (SSRO) in a split-mouth design (59). SSRO 
can sometimes result in postsurgical neurosensory disturbance. Al-Ahmad et al. (59) investigated 
whether or not a computer-assisted surgical guide for SSRO more effectively reduced the inci-
dence and severity of neurosensory complications than standard SSRO. With respect to tactile 
threshold, 67% of patients in the computer-assisted SSRO group had an abnormal threshold after 
one week in the lower lip and chin vs. 83% in the standard SSRO group (p<0.05). The tactile 
threshold was also significantly different in the chin after three months and the lower lip after six 
months. Likewise, two-point discrimination was significantly different in favour of the computer-
assisted SSRO group in the lower lip at one week and the chin at six months (p<0.05). Other out-
come measures, including direction of brush stroke and intraoperative parameters assessed by 
the surgeon, were equivalent between groups. 
 
[D0011] – What is the effect of 3D printed implants and cutting guides on patients’ body 
functions? 
[D0016] – How does the use of 3D printed implants and cutting guides affect activities of 
daily living? 
Function and activities of daily living were examined using two knee assessment scores, an oste-
oarthritis index, and clinical examination (in Brandao et al. (58)). Three RCTs (49-51) and two 
SRs (55,56) examined patients undergoing knee reconstruction, and one RCT examined mandib-
ular reconstruction patients. 
Knee Society Score (KSS) 
The KSS was developed as a simple, objective way to measure a patient’s function before and 
after TKA. KSSs range from 0 to 100, with 0 being the worst outcome and 100 being the best 
possible outcome. KSSs were reported in two RCTs and two SRs. In the two RCTs by Pfitzner et 
al. (51) and Boonen et al. (50), the scores were almost equivalent between groups in follow-up 
ranging from three months to two years, although pre- to post-operative scores increased radically 
(50,51). The two SRs by Thienpont et al. (55) and Mannan et al. (56) did not report any diffe-
rences in knee scores, but Thienpont et al. (55) reported a mean difference in KSS in favour of 
the 3D print group of 4.3 points (95% CI 1.5-7.2; p=0.003). This difference is not considered to be 
of clinical significance (50). 
Oxford Knee Scale 
The Oxford Knee Scale was reported in three studies (49,50,56). The meta-analysis showed a 
small and statistically insignificant pooled mean difference of 1.29 (95% CI -0.84-3.41; p=0.24) 
points in support of 3D print technology (moderate quality of evidence). There was a low degree 
of heterogeneity between studies (I
2
=0%, p=0.68; Figure 6.11). Mannan et al. (56) reported a 
statistically insignificant pooled mean difference of 0.48 points in support of standard surgery. 
Thus, the results can be regarded as imprecise and inconsistent using this scale (56). 
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Figure 6.11: 3D print vs. standard; outcome: Oxford Knee Score, patients undergoing knee recon-
struction 
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Quality of life 
[D0012] - What is the effect of 3D printed implants and cutting guides on generic health-
related quality of life? 
[D0013] - What is the effect of 3D printed implants and cutting guides on disease-specific 
quality of life? 
Quality of life: SF12, EQ5D, and OHIP14 scores 
Health-related quality of life (HRQoL) was evaluated in three RCTs (49,50,58): two in patients 
undergoing knee reconstruction (49,50) and one in mandibular reconstruction patients (58). Stu-
dies were of moderate quality. HRQoL was measured using the generic scores SF12 (Physical 
and Mental Component) and EQ5D, and the disease-specific OHIP-14 score (Oral Health Impact 
Profile) to evaluate the impact of interventions on oral HRQoL.  
Huijbrechts et al. (49) reported that physical and mental SF12 scores were not significantly diffe-
rent at three months (p=0.418 and p=0.267, respectively) or at one year (p=0.114 and p=0.569) 
post-operatively. Likewise, Boonen et al. (50) reported equal progressions in the intervention and 
standard groups using the EQ5D score. OHIP-14 scores in mandibular reconstruction patients 
showed a significant difference in favour of the 3D printed group (p=0.027) (58). 
 
Patient satisfaction 
[D0017] - Were patients satisfied with the use of 3D printed implants and cutting guides? 
Satisfaction was not reported in any study as an outcome and was not reported in any of the in-
cluded RCTs or cohort studies. 
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7   SAFETY (SAF) 
7.1   Research questions 
Element ID Research question 
C0008 
How safe is the use of 3D printed implants and cutting guides in relation to standard 
implants and cutting guides? 
C0004 How does the frequency or severity of harm change over time or in different settings? 
C0005 
What are the susceptible patient groups that are more likely to be harmed through the 
use of 3D printed implants and cutting guides? 
B0010 
What kind of data/records and/or registry is needed to monitor the use of 3D printed 
implants and cutting guides and standard implants and cutting guides? 
 
7.2   Results 
Included studies 
This domain included all studies from the EFF domain as well as three additional studies reporting 
safety concerns in maxillofacial and cranial surgery (61-63). Other safety issues not covered in 
these studies may exist as short and not long-term outcomes were generally examined.  
 
Patient safety 
[C0008] – How safe is the use of 3D printed implants and cutting guides in relation to 
standard implants and cutting guides? 
Knee surgery 
Few of the included studies included data on complications occurring in TKA comparing those 
undergoing patient-specific instruments (PSIs), patient-matched positioning guides (PMPGs), and 
navigation templates (NTs) and those using standard interventions. In these short-term studies, 
no additional complications associated with 3D printed implants and cutting guides in TKA were 
reported. In Huijbregts et al. (49), some of the most frequent complications were infection (10.1% 
vs. 10.9%), manipulation under anaesthetic (1.4% vs. 7.8%), venous thromboembolism (0% vs. 
1.6%) and haemarthrosis (1.4% vs. 0%) in the PSI group compared with the standard instrumen-
tation group, respectively. In Boonen et al. (50), some of the most frequent complications were 
infection (0% vs. 1.2%), manipulation under anaesthetic (4.9% vs. 2.5%), venous thromboembo-
lism (1.2% vs. 0%) and haemarthrosis (2.4% vs. 0%) in the PMPG group compared with standard 
instrumentation. In Zhang et al. (54), there was no difference in infection or venous thromboembo-
lism in the NT group compared with the standard intramedullary positioning group.  
Maxillofacial surgery 
One study examined complications in mandibular reconstruction comparing those assigned to 
computer-assisted mandibular reconstruction and those assigned to standard reconstruction. In 
Ayoub et al. (19), there was no significant difference in complication rate such as operating time 
or duration in the intensive care unit between the computer-assisted group and the standard 
group. However, there was a difference in ischaemic time, with a decrease in the computer-
assisted group. Two retrospective studies of small sample size which were not included in the 
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EFF domain evaluated operating times between 3D printing groups (5.5 ± 0.5 hours) and stan-
dard groups (6.5 ± 0.7 hours) and found significant differences (61). 
Cranial surgery 
Chrzan et al. (63) examined complication rates in cranioplasty between those undergoing com-
puter-aided design (CAD) modelling and those undergoing standard cranioplasty. There was a 
significant difference in mean operating time between the CAD group (120.3 minutes, 95% CI 
110-140) and the control group (136.5 minutes, 95% CI 120-150; p<0.000004). In a study not 
included in the EFF domain, only complications from standard cranioplasty were evaluated. The 
most frequently observed complications were wound infection (11.3%), bone resorption (6.5%), or 
sunken bone plates (1.6%). 
[C0004] – How does the frequency or severity of harm change over time or in different 
settings? 
Knee, maxillofacial surgery, or cranial surgery 
The included studies had some data on short-term outcomes in hospital settings but no infor-
mation on long-term complications to examine safety outcomes such as implant survival. There-
fore, it is not possible to further evaluate harm changes over time or to evaluate harm increases or 
decreases in different organisational settings such as implant failure, prosthesis problems, and 
continuing pain. 
[C0005] – What are the susceptible patient groups that are more likely to be harmed 
through the use of 3D printed implants and cutting guides? 
Knee, maxillofacial surgery or cranial surgery 
3D printed implants and cutting guides in TKA are not recommended in patients with previous 
knee replacement of the same knee. Caution should be exerted in patients with any metal device 
that affects image quality of the knee, angular deformities greater than 15° of fixed varus, valgus, 
or flexion, tibial slope exceeding 15°, or with moderate to severe bony deformities, Charcot knee, 
or patients with severe patella tendon calcification that may prevent patella eversion
8
. No infor-
mation is available concerning susceptible patient groups in mandibular reconstruction and crani-
oplasty. 
[B0010] - What kind of data/records and/or registry is needed to monitor the use of 3D 
printed implants and cutting guides and standard implants and cutting guides? 
Knee, maxillofacial surgery or cranial surgery 
In the developmental phase, the use of high-risk 3D-printed medical devices would only be al-
lowed in a selection of specialist centres (phase I and D). This is to avoid having high-risk medical 
devices widely adopted in many hospitals without a thorough evaluation of their safety and added 
value. Before an innovation becomes widespread, a formal scientific evaluation should have taken 
place within an appropriate study design in which a comparison is made with existing alternatives 
(phase A). The government can (co-)finance a system to use existing administrative databanks. 
                                                     
8
  
[http://synthes.vo.llnwd.net/o16/LLNWMB8/INT%20Mobile/Synthes%20International/Product%20Support%20Material/le
gacy_DePuy_PDFs/DSUS-JRC-0115-0698-1_LR.pdf] 
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The producer should first finance a study to evaluate outcomes that are not present in the admini-
strative databanks (such as comparative effectiveness in QoL) (3). 
Regarding long-term performance, all new procedures must be reported to a follow-up database/ 
registry to provide data on complication rates of 3D printed implants and cutting guides in TKA 
compared with standard instrumentation group(s). 
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8   DISCUSSION 
Description of technology and comparators 
The Belgian Health Care Knowledge Centre’s (KCE) health technology assessment on 3D prin-
ting applications for medical purposes (3) describes the regulation of medical devices for 
healthcare use and classifies different products according to their interaction with the human body 
from Class I to Class III. However, if the device falls under the definition of custom-made and not 
customisable, noting that the requirements for custom-made devices are less stringent, there is a 
risk of devices being commercialised without, for example, going through at least a CE mark pro-
cess.  
While a 3D printed prosthetic may be classified as Class I, or low risk, the technology has pro-
gressed sufficiently to produce more advanced implants and tools that would be defined as Class 
III, or high risk, medical devices; for example, surgical instruments, umbilical cord clamps for dis-
aster relief efforts, and new implantable medical devices to help heal fractured bones, as in this 
assessment. 
If such devices are mass produced on a 3D printer, then high-level, third-party oversight of safety, 
quality, and performance are mandatory. In Europe, that role is covered by CE mark notified bod-
ies that certify market access. However, if the device falls under the custom-made definition, third-
party oversight does not apply. 
Devices produced via a standard process and then adapted to the specific features of the patient 
are considered “custom-made” under the Medical Devices Directives (guidelines relating to the 
application of the Council Directive 90/385/EEC on active implantable medical devices and the 
Council Directive 93/42/EEC on medical devices (https://ec.europa.eu/growth/single-
market/european-standards/harmonised-standards/implantable-medical-devices_en). Historically 
this made sense, as custom-made items were typically low risk and few in number. However, as 
the number and complexity of custom-made devices has grown and become routine practice, 
health systems and regulators must ensure that they are subject to the same high-level scrutiny 
as mass-produced devices. New regulations should consider these aspects to ensure that the 
principles of ensuring safety and liability are secured.  
These issues pose another challenge to health authorities with regard to safety. Although the final 
directive has not been published, different proposals have been made such as: “…the assembly 
or adaptation must be in accordance with validated instructions provided by the manufacturer of 
the device to be adapted; and that, if an individual modifies a device … in such a way that compli-
ance with the essential principles may be affected, they shall assume the obligations incumbent 
on manufacturers". In this sense, the liability principle should be considered in order to trace who 
should be responsible for any damage caused by defects in the final product or its use. 
This goes some way towards fixing the problem of responsibility and response. If health providers 
were to print devices for their patients by strictly following instructions from the supplier, they 
would not be considered the manufacturer under this change. However, there are still challenges 
to identifying who is responsible for the device. 
Traditional definitions of manufacturer do not encompass the process of 3D printing custom-made 
implants and cutting guides. Generally speaking, it is assumed that the manufacturer who designs 
an item will manufacture that item. This is not always the case with the democratisation of 3D 
printing technology and the production of some medical devices. 
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Nevertheless, the directive is clear that all the producers involved in the production process are 
liable as well as all actors in the supply chain. 
Health problem 
3D printed medical devices are most frequently applied to knee, maxillofacial, and cranial surgery. 
The most frequent diseases in the included studies were primarily knee OA and secondary RA 
treated with TKA, oral cancer treated with mandibular reconstruction, and traumatic brain injury with 
intracranial hypertension treated with decompressive craniectomy and later cranioplasty. These are 
serious and global conditions, with oral cancer affecting over 300,000 people and TBI over 10 mil-
lion people each year, and approximately 1% of the population make contact with a doctor with 
symptoms of knee arthritis (45,46). The introduction of 3D print technology does not significantly 
change standard instrumentation procedures in TKA, mandibular reconstruction, or cranioplasty but 
it may improve outcomes. In Europe, 3D print technology only accounts for ~1.3% of the 1,324,000 
annual TKAs (1,2). In mandibular reconstruction and cranioplasty, there are no published data on 
the utilisation of the technologies in Europe, but 3D print technology is also growing in these clinical 
areas.  
Clinical effectiveness 
Thirteen studies reported on the use of surgical interventions using 3D print technology compared 
with standard interventions on patients undergoing knee, maxillofacial, or cranioplastic surgery. 
This assessment provided both a meta-analysis and a narrative summary on outcomes when 
meta-analysis was not possible. Overall, the evidence level for the included studies was very low 
to moderate, mainly due to the risk of bias and the imprecision of the estimates in the included 
studies, which might limit the robustness of our findings. 
Results by outcome 
Alignment 
This outcome was only reported in patients undergoing TKA. 
Number of outliers (by >3°) in TKA 
The number of outliers in relation to TKA was reported in six RCTs and one SR with respect to 
five separate outcomes: hip-knee-ankle angle (limb), coronal femoral angle, coronal tibial angle, 
tibial slope, and femoral rotation. Results from the meta-analysis and SR are presented in Table 
8.1. 
 
Table 8.1: Meta-analysis regarding alignment in 3D surgery vs. standard. Results from RCTs and SRs 
(Thienpont et al. (55)) 
Endpoints Results (OR) P-value Results SR* (RR) 
Hip-knee-ankle angle  0.29 in favour of 3D print <0.0001 0.79 in favour of 3D print (p=0.013) 
Coronal femur  0.24 in favour of 3D print <0.001 0.74 in favour of 3D print (p=0.043) 
Coronal tibial 0.29 in favour of 3D print 0.005 1.30 (p=0.13) 
Tibial slope  0.55  0.57 1.32 in favour of standard (p=0.001) 
Femoral rotation 0.33 0.16 0.97 (p=0.88) 
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Operating time  
In patients undergoing knee surgery, only minor differences in operating time were observed; 
however, differences were statistically significant, favouring 3D surgery patients compared with 
standard instrumentation. Estimates ranged from 4.4 to 10.7 minutes. The quality of the evidence 
was low and heterogeneity was high. No difference in overall operating time was found in maxilla-
facial patients. A significant difference of 16.2 minutes was found in one small study of craniopla-
sty patients favouring 3D surgery (very low quality of evidence). 
Other outcomes 
No significant or clinically relevant differences were found in pain scores and blood loss. In rela-
tion to function and activities of daily living, no differences in the two groups were found in knee 
scores between patients undergoing knee reconstruction. Only one of three health-related quality 
of life scores showed a significant difference in favour of the intervention group.  
In summary, 3D surgery using 3D printed implants and cutting guides in TKA compared with 
standard instrumentation resulted in greater precision, as demonstrated through outcomes such 
as malalignment (hip-knee-ankle angle, coronal femoral angle, and coronal tibial angle) or abso-
lute deviation. No other outcomes showed clinical or statistically significant results in favour of 3D 
surgery or standard surgery. Until further evidence is generated, these results may support the 
use of 3D print technology as an alternative to standard surgery, with the caveat that the quality of 
current evidence varies from very low to low. Use should be restricted to reference centres, and 
data on safety and efficacy must be collected. Patients should be informed about alternatives, 
possible benefits, and the risks. Earlier studies also support the use of 3D surgery until additional 
high-quality studies are produced (1). However, it is necessary to establish what if any relevant 
improvements 3D printed surgery offers before any final decision is made on continuing use of the 
technology. Proposed data collection systems by EUnetHTA JA3, WP5 offer a good starting point 
to standardise evidence generation while ensuring quality. 
Based on the available literature, it is challenging to weigh which outcomes/results are most im-
portant. From a patient perspective, patient-related outcomes such as functionality, QoL, and 
changes in sensory function seem to be most relevant. Unfortunately, it may be difficult to com-
ment on these effects on the basis of the literature, since these results are not particularly well 
quantified or established. It should also be mentioned that it is often not possible to determine 
which differences in effect sizes are clinically relevant when comparing groups. The outcomes 
suggestive of a relevant effect (alignment) are proxy outcomes, such that direct patient effects 
such as pain or QoL are not immediate, although larger alignment problems in TKA patients may 
result in functional difficulties. It has been shown that between 6 and 12% of TKAs fail as a result 
of malalignment of the components (49), and since malalignment may contribute to instability, 
aseptic loosening, and unexplained pain (49), precision in these procedures is of great im-
portance. As in this assessment and most studies concerning TKA patients, precision is demon-
strated through outcomes such as outliers (often defined as a deviation by >3° from the planned 
positioning of the implant) or absolute deviation in degrees. In support of this approach, Gan et al. 
(52) commented that biomechanics research has demonstrated that precisely restoring the lower 
extremity can be a very effective method to avoid polyethylene wear. The same authors also sug-
gested that increased contact pressure will lead to increased polyethylene wear, prosthesis loos-
ening, and TKA failure. Gan et al. (52) also reported 3° varus–valgus alignment of the lower limb 
in the frontal plane to be optimal, and Pfitzner et al. (51) pointed out that in the absence of long-
term studies, a neutral mechanical axis remains the gold standard. However, Huijbrechts et al. 
(49) said: "Future correlation with aseptic loosening is required to determine if the cumulative 
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deviation has clinical rather than mathematical value", and Thienpont et al. (55) said that "authors 
have concluded that the impact of mechanical coronal plane malalignment may be smaller than 
originally believed which may cast doubt on the premise of PSI". Future studies will need to 
demonstrate a relevant long-term impact of malalignment in TKA patients. Furthermore, it is im-
portant to note that the above results reflect the use of different 3D systems (Table 4.4, Table A1, 
Table A.2) and imaging modalities (MR and CT) and that intra- and inter-observer variability may 
influence alignment measurements (49). 
Safety 
Safety issues related to 3D print technology and standard instrumentation were examined in few 
of the included studies. There was no overall difference in complications between the technolo-
gies in TKA, mandibular reconstruction, or cranioplasty. A difference was found in ischaemic time 
in mandibular reconstruction, with a decrease in the 3D print group using individual surgical 
guides. The included studies only included data on short-term outcomes such as infection, venous 
thromboembolism, haemarthrosis, ischaemia, and operating time. Long-term complications such 
as harm change over time, implant failure, prosthesis problems, and continued pain are needed to 
fully evaluate which safety issues are relevant to this new technology (51,52,58). Another concern 
not accounted for is the associated exposure to ionising radiation triggered by the repeat CT-
scans acquired in many of the 3D print technologies. Although the risk for any person is small, the 
increased exposure to radiation when using 3D print technology is not negligible (64).  
Need for research/evidence gaps 
Well-prepared RCTs or prospective cohort studies with relevant comparisons in all areas of 3D 
print technology are required. Accordingly, there is still a need to illustrate whether or not the ef-
fects and complications of 3D print technology are different to standard surgery. Also, future stu-
dies need to better utilise standardised assessment tools and gold-standard assessments and 
explicitly present criteria when necessary in alignment studies. Furthermore, it will be relevant to 
assess patient-related outcomes such as functional outcomes and QoL as well as long-term out-
comes and complications such as implant survival and persistent pain. There also needs to be a 
focus on evaluation methods for 3D print technologies. The availability of CT and MRI and the 
recent developments in CAD software provide opportunities to update the evaluation methods for 
3D printing technologies and thereby deliver more reliable and accurate results.  
Another strategy for collecting information about the use of 3D printed implants and cutting guides 
could be to limit the use of 3D technology to a limited number of hospitals acting as reference 
centres. This offers a number of advantages, including better patient outcomes through concen-
trated expertise and, for devices without evidence of efficacy, opportunities for data collection. 
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9   CONCLUSION 
3D printed technology showed greater precision in terms of malalignment than standard instru-
mentation in TKA. However, the evidence was of very low or low quality. No firm conclusions can 
be drawn for mandibular reconstruction and cranioplasty, since no other outcomes showed clinical 
or statistically significant results in favour of either technology. The clinical implications of the fin-
dings in TKA are uncertain, and further research is needed to assess patient-related outcomes 
from the use of 3D print technology before any final decision on continued use of the technology. 
Regarding safety, while a few short-term outcomes such as infection, venous thromboembolism, 
and haemarthrosis were reported, there were no overall differences except from ischaemic time in 
mandibular reconstruction between the assessed technologies.  
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APPENDIX 1: METHODS AND DESCRIPTION OF THE EVIDENCE USED 
 
Documentation of the Search Strategies 
 
 
PubMed - primary studies:  
 Date: 03/04/2018 
 
 ID Search 
 #1 Printing, Three-Dimensional, [Mesh]  
 #2 Stereolithography, [Mesh]  
 #3 Computer-Aided Design, [Mesh]  
 #4 #1 OR #2 OR #3 
 #5 “rapid prototyping” 
 #6 “patient specific instruments” 
 #7 “Patient specific instrument” 
 #8 “Patient specific implant” 
 #9 “Patient specific implants” 
 #10 “Surgical guide” 
 #11 “Surgical guides” 
 #12 “Additive manufacturing” 
 #13 “Medical additive manufacturing” 
 #14 “Subtractive manufacturing” 
 #15 “Computer numerical machine” 
 #16 “3d printing” 
 #17 “Three dimensional printing” 
 #18 “3d-printing” 
 #19 “three-dimensional printing” 
 #20 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15   OR #16 OR #17 OR #18 OR #19 
 #21 #20 AND (Controlled Clinical trail [ptyp] OR Observational study [ptyp] OR Randomized Controlled trail [ptyp]) 
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 #22 #21 AND last 10 years [PDat] 
 #23 #22 AND Humans [Mesh] 
 
PubMed – Reviews 
 Date: 06/04/2018 
 
 ID Search 
 #1 Printing, Three-Dimensional, [Mesh]  
 #2 Stereolithography, [Mesh]  
 #3 Computer-Aided Design, [Mesh] 
 #4 #1 OR #2 OR #3 
 #5 “rapid prototyping” 
 #6 “patient specific instruments” 
 #7 “Patient specific instrument” 
 #8 “Patient specific implant” 
 #9 “Patient specific implants” 
 #10 “Surgical guide” 
 #11 “Surgical guides” 
 #12 “Additive manufacturing” 
 #13 “Medical additive manufacturing” 
 #14 “subtractive manufacturing” 
 #15 “Computer numerical machine” 
 #16 “3d printing” 
 #17 “Three dimensional printing” 
 #18 “3d-printing” 
 #19 “three-dimensional printing” 
 #20 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 
 #21 #20 AND (Systematic Reviews [ptyp] OR Meta-Analysis[ptyp]) 
 #22 #21 AND last 5 years [PDat] 
 #23 #22 AND Humans [Mesh] 
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EMBASE – Primary studies 
 Date: 06/04/2018 
 
 ID Search 
 #1 Three dimensional printing/exp 
 #2 Stereolithography/exp 
 #3 Computer aided design/exp 
 #4 #1 OR #2 OR #3 
 #5 “rapid prototyping” 
 #6 “patient specific instruments” 
 #7 “Patient specific instrument” 
 #8 “Patient specific implant” 
 #9 “Patient specific implants” 
 #10 “Surgical guide” 
 #11 “Surgical guides” 
 #12 “Additive manufacturing” 
 #13 “Medical additive manufacturing” 
 #14 “subtractive manufacturing” 
 #15 “Computer numerical machine” 
 #16 “3d printing” 
 #17 “Three dimensional printing” 
 #18 “3d-printing” 
 #19 “three-dimensional printing” 
 #20 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 
 #21 #20 AND ([controlled clinical trail]/lim OR [randomized controlled trail]/lim) 
 #22 [2008-2018]/py 
 #23 #22 AND [Humans]/lim  
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EMBASE – Reviews 
 Date: 06/04/2018 
 
 ID Search 
 #1 Three dimensional printing/exp 
 #2 Stereolithography/exp 
 #3 Computer aided design/exp 
 #4 #1 OR #2 OR #3 
 #5 “rapid prototyping” 
 #6 “patient specific instruments” 
 #7 “Patient specific instrument” 
 #8 “Patient specific implant” 
 #9 “Patient specific implants” 
 #10 “Surgical guide” 
 #11 “Surgical guides” 
 #12 “Additive manufacturing” 
 #13 “Medical additive manufacturing” 
 #14 “subtractive manufacturing” 
 #15 “Computer numerical machine” 
 #16 “3d printing” 
 #17 “Three dimensional printing” 
 #18 “3d-printing” 
 #19 “three-dimensional printing” 
 #20 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 
 #21 #20 AND ([systematic review]/lim OR [meta analysis]/lim) 
 #22 [2013-2018]/py 
 #23 #22 AND [Humans]/lim 
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 Cochrane 
 Date: 06/04/2018 
 
 ID Search  
 #1 MeSH descriptor: [Printing, Three-Dimensional] explode all trees  
 #2 MeSH descriptor: [Stereolithography] explode all trees  
 #3 MeSH descriptor: [Computer-Aided Design] explode all trees 
 #4 #1 or #2 or #3 Publication Year from 2008 to 2018  
 #5 "rapid prototyping" Publication  
 #6 "patient specific instruments"  
 #7 "patient specific instrument"  
 #8 "patient specific implants"  
 #9 "patient specific implant"  
 #10 "Surgical guides"  
 #11 "Surgical guide"  
 #12 "additive manufacturing"  
 #13 "medical additive manufacturing"  
 #14 "subtractive manufacturing"  
 #15 "computer numerical machine"  
 #16 "3d printing"  
 #17 "Three dimensional printing"  
 #18 "3d-printing"  
 #19 "Three-dimensional printing" 
 #20 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19  
 #21 #4 or #20 Publication Year from 2008 to 2018  
  
 A search on on-going clinical trials has been performed on ClinicalTrails.gov and Clinicaltrailsregister.eu. In both databases the search word was 3D. The search was 
performed the 19th of February 2018.  
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Evidence tables of individual studies included for clinical effectiveness and safety 
 
Table A.1: Characteristics and extraction table of randomised controlled studies  
Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Huijbregts 
et al., 
2016 
RCT 140 knees in patients 
with end-stage 
rheumatoid or 
osteoarthritis (75 in 
PSI group with mean 
age of 66.7 and 65 in 
standard group with 
mean age of 69.0) 
 
Intervention: PSI 
Comparator: Standard instrumentation 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: Medial parapatellar 
approach with implanting a cemented knee arthroplasty and 
patellar resurfacing when necessary  
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: No information 
PSI imaging modality: MRI 
PSI System: Visionaire® 
PSI Implant: Legion systems or Genesis II 
Standard implant: Legion systems or Genesis II 
Accuracy of component 
positioning and alignment 
in TKA 
Operating time, rate of 
early complications, OKS, 
and SF-12 scores. 
Measurement tools: 
Radiographs, CT scans 
and questionnaires 
Length of follow-up: 1 
year 
Loss to follow-up: n=2 in 
PSI group and n=1 in 
standard group 
 
Outliers >3⁰ deviation from planned 
alignment: 
Hip Knee Ankle-angle (limb): ND 
Coronal femur: ND 
Coronal tibia: ND 
Tibial slope: Significant different in favour of 
standard care with 13% vs .20% outliers 
(p= 0.032) 
Femoral rotation: ND 
Operating time: ND 
OKS: ND 
Physical and mental SF-12: ND 
Boonen et 
al., 2016 
Multicentre, 
double-blind 
RCT 
180 patients with knee 
osteoarthritis (90 in 
PMPG group with 
mean age of 69 and 
90 in the standard 
group with mean age 
of 65) 
 
Intervention: PMPG 
Comparator: Standard instrumentation. 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: Medial parapatellar 
approach with implanting a cemented knee arthroplasty and 
patellar resurfacing where necessary. 
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: Materialise NV, Leuven, Belgium  
PMPG imaging modality: MRI 
PMPG System: Signature 
PMPG Implant: Vanguard 
Standard implant: No information 
KSS, OKS, WOMAC, 
VAS, EQ-5D-3L index 
score, EQ-5D-3L VAS 
health and rate of 
complications 
Measurement tools: 
Questionnaires 
Mean follow-up: 44 
months 
Loss to follow-up: n=8 in 
PMPG group and 9 in the 
standard group 
 
KSS: ND 
OKS: ND 
WOMAC: ND 
VAS: ND 
EQ-5D: ND 
EQ-5D VAS: ND 
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Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Pfitzner et 
al., 2014 
RCT 90 patients with 
primary knee 
osteoarthritis (30 in 
CT-based PSI group 
with a mean age of 63, 
30 in the MRI-based 
PSI group with a mean 
age of 65, and 30 in 
the standard 
instrumentation group 
with a mean age of 
64) 
Intervention: CT- or MRI-based PSI 
Comparator: Standard instrumentation  
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: Posterior stabilized 
cemented TKA 
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: No information 
PSI imaging modality: CT or MRI 
CT-based PSI System: TruMatch® 
CT-based PSI Implant: Sigma® (Press-fit condylar) 
MRI-based PSI System: Visionaire® 
MRI-based PSI Implant: Journey® 
Standard implant: Journey® 
Accuracy of component 
positioning and alignment 
in TKA 
KSS, WOMAC, and 
operating time  
Measurement tools: 
Long leg radiographs, CT 
scans and 
questionnaires 
Mean follow-up time: 3 
months 
Loss to follow-up: None  
 
 
Outliers >3⁰ deviation from planned 
alignment: 
Hip Knee Ankle-angle (limb): CT-based 
group: ND 
MRI-based group: Significant different in 
favour of PSI with 7% vs. 43% outliers (p= 
0.002) 
Coronal femur: ND in both groups 
Coronal tibia: ND in both groups 
Tibial slope: ND in both groups  
Femoral rotation: CT-based group: 
Significant different in favour of PSI with 
13% vs 50% outliers (p= 0.01) 
MRI-based group: ND 
Operating time: CT-based group: 
Significant different in favour of PSI with 63 
min vs. 76 min (p< 0.001) 
MRI-based group: Significant different in 
favour of PSI with 58 min vs. 76 min (p< 
0.001) 
KSS: No difference 
WOMAC: No difference 
Gan et al., 
2015 
RCT  70 patients with 
serious knee 
osteoarthritis (35 in 
the NT group with 
mean age of 68.5, and 
35 in the standard 
group with mean age 
of 67.8) 
Intervention: Patient-specific navigational template  
Comparator: Standard instrumentation 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: 
Medial parapatellar approach with patellar eversion. 
Material of 3D printed device: Acrylate resin 
Type of printer used: Stereolithography, a rapid prototyping 
technique (Hen Tong Company, China) 
Software used: Materialise NV, Leuven, Belgium 
Imaging modality: CT 
NT System: No information 
NT implant: Scorpio Posterior Stabilized System 
Standard implant: Scorpio Posterior Stabilized System 
Accuracy of component 
positioning and alignment 
in TKA 
Operating time and 
degree of blood loss. 
Loss to follow-up: None 
 
Outliers >3⁰ deviation from planned 
alignment: 
Hip Knee Ankle-angle (limb): Significant 
different in favour of NT group with 1 vs. 8 
outliers (p< 0.001) 
Coronal femur: Significant different in 
favour of NT group with 1 vs. 9 outliers (p< 
0.001) 
Coronal tibia: Significant different in favour 
of NT group with 1 vs. 10 outliers (p< 
0.001) 
Operating time: Significant different in 
favour of NT group with 63 min vs. 76 min 
(p< 0.001) 
Blood loss: Significant different in favour of 
NT group with 200 ml vs. 290 ml (p< 0.001) 
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Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Qiu et al., 
2017 
 
RCT 26 patients with end-
stage knee 
osteoarthritis (10 in 
PSI group with mean 
age of 67.6 and 16 in 
the standard 
instrumentation group 
with mean age of 
65.5) 
 
Intervention: PSI 
Comparator: Standard instrumentation group.  
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: Medial parapatellar 
approach with implanting a cemented knee arthroplasty and 
patellar resurfacing where necessary. 
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: Arigin 3D Surgical Templating  
Imaging modality: CT 
PSI System: Arigin 3D Surgical Templating  
PSI Implant: No information 
Standard implant: No information 
Accuracy of component 
positioning and alignment 
in TKA  
 
Deviation from planned alignment: 
Hip Knee Ankle-angle (limb): Significant 
different in favour of PSI with 0.77⁰ vs. 
3.13⁰ (p< 0.05) 
Coronal femur: Significant different in 
favour of PSI with 0.37⁰ vs. 2.35⁰ (p< 0.05) 
Coronal tibia: Significant different in favour 
of PSI with 0.11⁰ vs. 1.09⁰ (p< 0.05) 
Zhang el. 
at., 2016 
Single-blind 
RCT 
40 patients with knee 
osteoarthritis (20 in 
the NT-group with 
mean age of 63, and 
20 in the standard 
intramedullary 
positioning group with 
mean age of 62.1)  
Intervention: NT 
Comparator: Standard intramedullary positioning 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: No information 
Material of 3D printed device: No information 
Type of printer used: SPSS 350B solid laser rapid prototyping 
machine (Shanxi Hengtong Intelligent Machine Co., China) 
Software used: Imageware 12.0 
Imaging modality: CT 
NT System: No information 
NT implant: Triathlon  
Standard implant: Triathlon 
Accuracy of component 
positioning and alignment 
in TKA  
Operating time, 
intraoperative 
haemorrhage volume 
Follow-up time: 12 
months 
Loss to follow-up: : n=2 
in NT group and 2 in CIP 
group 
 
Deviation from planned alignment: 
Hip Knee Ankle-angle (limb) : Significant 
different in favour of NT group with 0.6⁰ vs 
2.7 (p= 0.0435) 
Sagittal femoral: ND 
Coronal tibia: Significant different in favour 
of NT group with 0.7⁰ vs. 1.9 (p= 0.0456) 
Operating time: Significant different in 
favour of NT group with 46.8 min vs. 57.5 
min (p= 0.0086) 
Blood loss: ND 
 
 
Custom-made 3D printed implants and cutting guides in knee, maxillofacial, or cranial surgery  
 EUnetHTA Joint Action 3 WP4   71 
Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Brandão 
et al., 
2016 
 
Single-centre, 
double-blind 
RCT 
40 patients (22 in 
surgical guide group 
and 18 in control 
group) with median 
age of 43.5 requiring 
mandibular 
reconstruction 
Intervention: Surgical guides 
Comparator: Standard surgery 
Application type: Mandibular reconstruction 
Anatomic location of implant: Mandible 
Description of the surgical procedure: No information 
Material of 3D printed device: Acrylic resin 
Type of printer used: No information 
Software used: No information 
Imaging modality: CT 
Surgical guide: Custom made 
Standard surgery: Without surgical guides 
Occlusion pattern and 
stability 
Opening deviation 
Maxillomandibular 
relationship 
Loss of prosthetic space 
Esthetic preparation 
Diet, speech, oral 
competence and 
QoL 
Length of follow-up: 18 
months 
Loss to follow-up: 4 
patients 
Measurement tools: 
Clinical examination, CT 
scans and questionnaires 
 
Surgical guide group vs control group 
Occlusion pattern change: Significant 
different in favour of surgical guide group 
with 0% vs. 66.7% (p= 0.032) 
Occlusion stability: ND 
Opening deviation: ND 
Favourable maxillomandibular 
relationship: Significant different in favour 
of surgical guide group with 77.3% vs. 
44.4% (p= 0.035) 
Loss of prosthetic space: ND 
Diet, speech and oral competence: ND 
QoL: Significant different in favour of 
surgical guide group (p=0.027) 
 
Ayoub et 
al., 2014 
 
RCT 
 
20 patients (10 in 
rapid prototyping 
group with mean age 
of 52.3 and 10 in 
control group with a 
mean age of 54.7) 
requiring mandibular 
reconstruction 
Intervention: CAD and rapid prototyping of individually pre-
operative adjusted cutting guide 
Comparator: Standard treatment 
Application type: Mandibular reconstruction 
Anatomic location of implant: Mandible 
Description of the surgical procedure: No information 
Material of 3D printed device: Polyamide 
Type of printer used: Laser sintering 
Software used: 3matic-Software, Materialise NV, Leuven, 
Belgium 
Imaging modality: CT 
Surgical guides: Custom made 
Standard surgery: Without surgical guides 
Time for harvesting and 
shaping the transplant, 
reconstruction, 
osteosynthesis, ischemia 
and overall operating time 
Size of harvested bone 
ICU time 
Postoperative 
hospitalization time 
Blood transfusion 
Condyle position 
Intercondylar distance 
Transplant fail 
Loss to follow-up: None 
Measurement tools: 
Clinical examination and 
CT scan 
 
 
Rapid prototyping group vs. standard  
Time shaping donor site: Significant 
different in favour of standard group with 
37.8 min vs. 62.1 min (p< 0.005) 
Time shaping defect site: Significant 
different in favour of rapid prototyping group 
6.2 min vs. 20.3 min (p<0.001) 
Time for the osteosynthesis: Significant 
different in favour of rapid prototyping group 
with 10.1 min vs. 18.2 min (p<0.005) 
Overall reconstruction time: Significant 
different in favour of rapid prototyping group 
with 16.4 min vs. 38.5 min (p<0.001) 
Ischemic time: Significant different in favour 
of rapid prototyping group with 96.1 min vs. 
122.9 min (p<0.005) 
Overall operating time: ND 
ICU time: ND 
Postoperative hospitalisation time: ND 
Blood transfusion: ND 
Intercondylar distance (pre- vs. post-
surgery): Significant different in favour of 
rapid prototyping group with 1.3mm vs. 5.5 
mm (p<0.001) 
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Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Al-Ahmad 
et al., 
2013 
Double-blind, 
RCT, split-
mouth design 
8 patients scheduled 
for bilateral sagittal 
split ramus osteotomy 
(SSRO) (8 sides in 
Computer-assisted 
SSRO group and 8 
sides in the standard 
SSRO group) with a 
mean age of 23. 
Intervention: Computer-assisted SSRO  
Comparator: Standard SSRO 
Application type: Mandibular SSRO 
Anatomic location of implant: Mandible 
Description of the surgical procedure: Obwegeser-Dal Pont 
technique 
Material of 3D printed device: Acrylic resin 
Type of printer used: ZCorp Z310 
Software used: Solid Planner, Solid Model Co. 
Imaging modality: CT 
Surgical guides: Custom-made 
Standard surgery: Without surgical guides 
On four cutaneous points: 
Tactile threshold, two-
point discrimination and 
direction of brush stroke. 
Subjective changes in 
sensory function 
Intraoperative parameters 
assessed by surgeon 
Length of follow-up: 6 
months 
Measurement tools: 
Semmes-Wein-stein 
monofilaments 
Computer-assisted SSRO vs. standard 
SSRO (time after surgery): 
Tactile threshold: Significant different in 
favour of computer-assisted SSRO group 
with 67% abnormal threshold after 1 week 
at lower lip and chin vs. 83% abnormal 
threshold (p< 0.05). Significant difference 
also at the chin after 3 months and lower lip 
after 6 months. 
Two-point discrimination: Significant 
different in favour of computer-assisted 
SSRO group at lower lip at 1 week and chin 
at 6 months (p< 0.05). 
Direction of brush stroke: ND 
Subjective changes in sensory function: 
Significant different in favour of computer-
assisted SSRO group at 1 week 
Intraoperative parameters assessed by 
surgeon: ND 
Abbreviations: CT=Computerised tomography; EQ-5D-3L index score=EuroQol-5D-3L VAS health; FFC=Frontal femoral component angle; FTC=Frontal tibial component; HKA angle-Hip-Knee-Ankle angle; KSS=Knee Society 
Score; LTC=Lateral tibial component; ND=No difference; NT group=Navigation Template group; OKS=Oxford Knee Scores; PMPGs=Patient-matched positioning guides; PSI=Patient-specific instrumentation; RCT=Randomised 
controlled trial; SF-12=ShortForm-12 scores; TKA=Total knee arthroplasty; VAS=Visual analogue scale; WOMAC=Western Ontario and McMaster osteoarthritis index.  
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Table A.2: Characteristics and extraction table of other relevant studies  
Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Thienpont 
et al., 
2017 
Systematic 
Review and 
Meta-Analysis 
Search date: 
2011 through 
2015 
Databases: 
PubMed and 
Embase 
Included 
studies: 44 (20 
RCT and 24 
cohorts) 
5,822 knees (2,866 
PSI group and 2,956 
standard care group) 
Eligibility criteria: PSI 
and standard 
instrumentation 
compared, primary 
TKA, a least 1 of the 
study outcomes 
reported, English, 
French, German or 
Dutch language 
studies, follow-up >6 
month 
 
Intervention: PSI 
Comparator: Standard instrumentation 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: No information 
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: No information 
Imaging modality: CT or MRI 
PSI System: Visionaire, Sinature, Zimmer PSI, TruMatch or 
MyKnee 
PSI Implant: No information 
Standard implant: No information 
Malalignment 
coronal/sagittal 
(mechanical axis, tibia or 
femur) and KSS (knee 
and function) 
Operative time, tourniquet 
time, and blood loss 
PSI vs. standard (Relative risk of axis 
malalignment): 
Mechanical axis: 0.79 (CI 0.65-0.95) 
p=0.013 
Coronal tibia: ND 
Sagittal tibia: 1.32 (CI 1.12-1.56) p=0.001 
Coronal femur: 0.74 (CI 0.55-0.99) p=0.043 
Sagittal femur: ND 
Operating time (mean difference in 
minutes): -4.4 (CI -7.2- -1.7) p=0.002 
Blood loss: (mean difference in ml): -37.9 
(CI -68.4- -7.4) p=0.015 
Tourniquet time: ND  
KSS (Knee): ND 
KSS (Function) (mean difference): 4.3 (CI 
1.5-7.2) p=0.003 
Mannan 
et al., 
2016 
Systematic 
Review and 
Meta-analysis 
Search date: 
2000-2015 
Databases: 
PubMed, 
Cochrane 
Collaboration 
Trial registry 
and library, 
MEDLINE and 
Embase 
Included 
studies:  
8 (5 RCT´s 
and 3 
prospective-
comparative) 
 
828 knees (418 in PSI 
group and 412 in 
standard 
instrumentation group) 
Inclusion criteria: 
Level of evidence 1 or 
2, PSI and standard 
instrumentation 
compared ≥10 
patients in each group, 
reporting mean and 
sd, and English 
language studies.  
Exclusion criteria: 
Fracture deformity, 
tumor, animal, 
cadaveric studies.  
Intervention: PSI 
Comparator: Standard instrumentation 
Application type: TKA 
Anatomic location of implant: Knee 
Description of the surgical procedure: No information 
Material of 3D printed device: No information 
Type of printer used: No information 
Software used: No information 
Imaging modality: CT or MRI 
PSI System: Visionaire, TruMatch Sinature or MyKnee 
PSI implant: Genesis II, Nexgen, Press-fit condylar, Journey, 
Vanguard or GMK 
Standard implant: No information  
Postoperative KSS (knee 
and function) and range of 
movement 
Postoperative OKS and 
WOMAC scores 
PSI vs. standard: 
KSS (Knee): ND 
KSS (Function): ND 
ROM: ND 
OKS: ND 
WOMAC: ND 
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Authors 
and year 
Study type Number of patients/ 
patient 
characteristics 
Intervention(s) vs. comparison(s) and characteristics Main endpoint(s) Results 
Mazzoni 
et al., 
2013 
Prospective 
Comparative 
Study 
12 oncology patients 
with tumor lesions (7 
in prosthetically 
guided surgery group 
and 5 in control group) 
requiring mandibular 
reconstruction 
Intervention: Prosthetically guided maxillofacial surgery to 
produce custom made guides and reconstructive plate 
Comparator: Standard reconstruction with indirect 
CAD/computer-aided manufacturing procedure 
Application type: Mandibular reconstruction 
Anatomic location of implant: Mandible 
Description of the surgical procedure: No information 
Material of 3D printed device: Cobolt-chrome-molybdenum 
(cutting guide) and Titanium (bone plate) 
Type of printer used: No information 
Software used: CMF-Software, version 6.0, Materialise, 
Leuven, Belgium 
Imaging modality: CT 
Midline deviation (vertical 
and horizontal) 
Variation in planes of the 
mandibular angle 
Angular deviation of the 
mandibular arch 
Condyle position 
Measurement tools: 
Clinical examination and 
radiographs 
Follow-up time: 1 month 
 
Surgery accuracy evaluation test group 
vs control group : 
Midline deviation (vertical and horizontal): 
ND 
Mandible angle-shift right: ND 
Mandible angle-shift left: Significant 
different in favour of test group with 1.4 mm 
vs. 5.042 mm (p< 0.006) 
Angular deviation of the mandibular arch: 
ND 
Condyle position right: Significant different 
in favour of test group with mean 1.297 mm 
vs..4.458 mm (p= 0.035) 
Condyle position left: ND 
 
Chrzan et 
al., 
2012 
Prospective 
Comparative 
Study 
39 patients (19 in 
rapid prototyping 
group at the age of 21-
54 and 20 in control 
group at the age of 18-
60) requiring 
cranioplasty 
Intervention: CAD and rapid prototyping of individually pre-
operative adjusted prosthesis 
Comparator: Standard instrumentation with manually adjusted 
prosthesis 
Application type: Cranioplasty 
Anatomic location of implant: Skull 
Description of the surgical procedure: No information 
Material of 3D printed device: Polypropylene-polyester or 
aluminium-silicon 
Type of printer used: Milling Arrow 500 
Software used: CATIA (Dassault Systémes, Vélizy-
Villacoublay, France) 
Imaging modality: CT 
CAD implant: Codubix  
Standard implant: Manually adjusted prosthesis 
Operating time 
Surgeons opinion 
Rapid prototyping group vs. standard  
Operating time: Significant different in 
favour of rapid prototyping group with 120.3 
min vs. 136.5 min (p< 0.001) 
Abbreviations: CT scans Computerised tomography, EQ-5D-3L index score EuroQol-5D-3L VAS health, FFC Frontal femoral component angle, FTC Frontal tibial component, HKA angle Hip-Knee-Ankle angle, KSS Knee Society 
Score, LTC Lateral tibial component, ND No difference, NT group Navigation Template, group OKS Oxford Knee Scores, PMPGs Patient-matched positioning guides, PSI Patient-specific instrumentation, RCT Randomised controlled 
trial, SF-12 ShortForm-12 scores, TKA Total knee arthroplasty, VAS Visual Analogue scale, WOMAC Western Ontario and McMaster osteoarthritis index. 
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List of on-going and planned studies 
 
Table A.3: List of on-going studies with custom-made or customisable 3D printed implants and cutting guides for knee, maxillofacial or cranial surgery 
Study Identifier Estimated 
completion date 
Study type Number  
of patients 
Intervention Comparator Patient population Endpoints 
NTC03292679 
Craniofacial 
Applications of 3D 
printing 
September 2019 
Status: Not yet 
recruiting  
RCT 60 Subjects that are randomised into Arm 
B will have custom models of relevant 
portions of their facial skeleton printed 
and used as templates for bending 
and shaping plates for stabilising the 
fracture(s). 
Subjects that are 
randomized into Arm A 
will have their fractures 
repaired in the usual 
fashion i.e. using plates 
that are bent by free 
hand. 
12 years and older (Child, 
Adult, Older Adult)  
Sex: All 
Operative time 
NCT03057223 
Three-Dimensional 
Printing of Patient-
Specific Titanium 
Plates in Jaw Sur-
gery: A Pilot Study 
July 2021 
Status: Recruiting  
Interventional 
no 
randomisation  
48 3D-printed patient-specific titanium 
plates will be used in patients. 
No comparator  18 years and older (Adult, 
Older Adult) 
Intraoperative 
success rate 
Incidence of 
postoperative 
adverse events 
(Safety) 
 NCT02914431 
Personalised 
Titanium Plates vs 
CAD/CAM Surgical 
Splints in Maxillary 
Repositioning of 
Orthognathic 
Surgery 
December 2019 
Status: Not yet 
recruiting  
RCT 72 The cutting guides will be placed into 
the planned position. The 11 screw 
holes will be drilled using the 
predetermined screw holes on the 
guides. The osteotomy / ostectomy will 
then start. Next, the 3D printing 
personalised maxillary fixation plates 
will be adapted to reposition the Le 
Fort I segment to the planned position. 
The 11 screw holes on the bones 
defined by the cutting guides will be 
used again as the bony reference. The 
personalised plate will be first firmly 
installed on the maxilla above the 
osteotomy line by aligning the 
corresponding 5 screw holes on the 
plate to the bone. Afterwards, the 
osteotomised Le Fort I segment will be 
moved and rotated until all the 
remaining corresponding 6 screw 
holes on bone and plate are aligned. 
After the LeFort I 
osteotomy, the 
intraoperative 
repositioning of the 
maxilla will be 
accomplished using 
CAD/CAM surgical 
splints and the fixation of 
the maxilla is 
accomplished using 
commercial titanium 
plates. 
18 years to 35 years Difference of the 
maxillary 
position 
Operative time 
Intraoperative 
blood loss 
Cost of 
treatment 
Abbreviations: RCT=Randomised controlled trial; CAD: Computer-aided design; CAM=Computer-aided manufacturing 
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Table A.4: GRADE profile. 3D-print technology compared to standard instrumentation in knee surgery 
Certainty assessment № of patients Effect 
Certainty Importance 
№ of 
studies 
Study  
design 
Risk of  
bias 
Inconsistency Indirectness Imprecision 
Other  
considerations 
3D-print 
technology 
usual 
care 
Relative 
(95% CI) 
Absolute 
(95% CI) 
Hip-knee-ankle alignment (degrees) 
4  randomised 
trials  
serious 
a
 not serious  not serious  serious 
d
 none  21/174 
(12.1%)  
44/145 
(30.3%)  
OR 0.29 
(CI 0.16-
0.52)  
191 fewer 
per 1.000 
(119-238)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
Absolute deviation in degrees 
2  randomised 
trials  
very 
serious 
a
 
not serious  not serious  serious 
d
 none  79  80  -  mean 1.28 
degrees 
lower 
(3.29-0.74)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Operating time 
3  randomised 
trials  
serious 
b
 not serious  not serious  serious 
d
 none  122  117  -  mean 9.47 
minutes 
lower 
(18.1-0.84)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
Oxford Knee Score (OKS) (1 year follow-up) 
2  randomised 
trials  
serious 
a
  not serious  not serious  not serious  none  148  141  -  mean 1.29 
points 
higher 
(0.84-3.41)  
⨁⨁⨁◯ 
MODERATE  
IMPORTANT  
Knee Society function score (3 month follow-up) 
2  randomised 
trials  
serious 
a
 not serious  not serious  serious 
d
 none  120  120  -  median 0  
(0)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
Proportion of outliers (> 3°) - coronal femur 
4  randomised 
trials  
serious 
a
 not serious  not serious  serious 
d
 none  10/174 (5.7%)  31/145 
(21.4%)  
OR 0.24 
(0.09-0.68)  
153 fewer 
per 1.000 
(58-190)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
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Certainty assessment № of patients Effect 
Certainty Importance 
№ of 
studies 
Study  
design 
Risk of  
bias 
Inconsistency Indirectness Imprecision 
Other  
considerations 
3D-print 
technology 
usual 
care 
Relative 
(95% CI) 
Absolute 
(95% CI) 
Proportion of outliers (> 3°) - coronal tibia 
4  randomised 
trials  
serious 
a
 not serious  not serious  serious 
d
 none  9/174 (5.2%)  25/145 
(17.2%)  
OR 0.29 
(0.12-0.69)  
115 fewer 
per 1.000 
(47-148)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
Proportion of outliers (> 3°) - tibial slope 
3  randomised 
trials  
serious 
a
 serious 
c
 not serious  serious 
d
 none  27/139 
(19.4%)  
23/110 
(20.9%)  
OR 0.91 
(0.50-1.66)  
15 fewer 
per 1.000 
(92-96)  
⨁◯◯◯ 
VERY LOW  
 
Abbreviations: CI=confidence interval; OR=odds ratio  
Explanations a. Unclear risk of bias related to blinding in included studies. High risk of bias related to randomisation and allocation in study by Qui et al., 2017 b. Studies affected by unclear risk of bias in many domains. c. Down-
graded to serious because of high heterogeneity between studies and confidence intervals of point estimates do not overlap. d. downgraded to serious because of broad confidence intervals. 
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Applicability tables 
 
Table A.5: Summary table characterising the applicability of a body of studies 
Domain Description of applicability of evidence 
Population The target population for this assessment is adult patients (>18 years) undergoing knee, 
maxillofacial, or cranial surgery. The target population of this assessment did not differ from 
the population enrolled in the included studies. The most frequent diseases in the included 
studies are primarily knee osteoarthritis and secondary rheumatoid arthritis treated with 
total knee arthroplasty (TKA), oral cancer treated with mandibular reconstruction, and 
traumatic brain injury with intracranial increased pressure treated with decompressive 
craniectomy and later cranioplasty. Patients undergoing TKA were generally older than 
other patient groups.  
Intervention The technology described in this assessment is related to the use of 3D printers for the 
production of custom-made or customisable 3D printed implants and cutting guides for 
improving outcomes in patients undergoing knee, maxillofacial, or cranial surgery. 
The interventions in the included studies cover a wide range of 3D technologies concerning 
materials, printers, and software and different ways of combining these parts in the 
process. 
Comparators The comparator is standard produced implants and cutting guides which also reflect a 
variety of procedures not always well described in the included studies.  
Outcomes Effectiveness outcomes most frequently reported in the included studies were alignment 
and precision, but also functional outcomes were reported. Regarding safety issues, the 
follow-up period was often too short to report on durability/longevity in relation to 3D print 
technology. 
Setting The studies included enrolled patients in Germany, Brazil, China, Italy, Poland, Australia, 
England, Jordan, Switzerland, and The Netherlands in a hospital setting.  
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APPENDIX 2: CHECKLIST FOR POTENTIAL ETHICAL, ORGANISATIONAL, 
PATIENT AND SOCIAL AND LEGAL ASPECTS 
1. Ethical  
1.1. Does the introduction of the new technology and its potential use/non-use 
instead of the defined, existing comparator(s) give rise to any new ethical is-
sues? 
Yes/No 
1.2. Does comparing the new technology to the defined, existing comparators point 
to any differences that may be ethically relevant? 
Yes/No 
2. Organisational  
2.1. Does the introduction of the new technology and its potential use/non-use 
instead of the defined, existing comparator(s) require organisational changes? 
Yes/No 
Organisational changes are inevitable if one should decide to implement the use of 3D printed implants and 
surgical guides as a supplement to or as a replacement for standard implants and surgical guides. The 
whole process of creating data for image editing and producing the device will change and involve the hos-
pital and the individual health professional in new ways. These changes will mainly consist of changes in 
work flow at the hospital department and changes in competences for the personal. The impact of these 
changes depends on the organisational scenario implemented. The use of 3D printed implants and surgical 
guides could be organised in many ways and with different consequences. 
 The implants and surgical guides could be printed locally in each department where they are used 
 The implants and surgical guides could be printed at each hospital in a central printing department 
and then distributed to local departments afterwards 
 The implants and surgical guides could be printed in a central printing department established by all 
hospitals in a region or a country 
 The implants and surgical guides could be printed by a private external manufacturer and send to 
the hospital departments afterwards. These manufacturers could both be national and international 
These different ways of organising the printing process for 3D printed implants and surgical guides will place 
different demands on the organisation, and there is a huge differences in the skills required in house. The diffe-
rent scenarios for organising the 3D printing process also come with different legal requirements. See the para-
graph below.  
2.2. Does comparing the new technology to the defined, existing comparator(s) 
point to any differences that may be organisationally relevant? 
Yes/No 
See above (section 2.1) 
3. Social  
3.1. Does the introduction of the new technology and its potential use/non-use 
instead of the defined, existing comparator(s) give rise to any new social is-
sues? 
Yes/No 
3.2. Does comparing the new technology to the defined, existing comparator(s) 
point to any differences that may be socially relevant? 
Yes/No 
4. Legal   
4.1. Does the introduction of the new technology and its potential use/non-use 
instead of the defined, existing comparator(s) give rise to any legal issues? 
Yes/No 
The following legal issues have been identified by KCE in their report on "Responsible use of high-risk med-
ical devices: The example of 3D printed medical devices" (3) and may be relevant to address in this as-
sessment as well. For a thorough discussion of more legal aspects of the issue, please see the above-
mentioned report: 
 Requirements for market access: In the current EU regulations, the requirements for putting 3D prin-
ted medical devices on the market depends on their classification as a "standard", "customisable", or 
"custom-made" device. "Custom-made" devices are unique devices fitted to an individual patient, 
whereas "customisable" medical devices are devices that can be (mass) produced via a standard pro-
cess and individualised according to individual parameters. Currently, customisable devices are regard-
ed as prescription devices that are made once for a certain patient. As a consequence, they are usually 
classified with the custom-made devices. In contrast to "standard" medical devices, manufacturers of 
custom-made medical devices, regardless of the risk profile, do not need to apply any CE marking to 
their product, there are no specific quality system requirements and, for the higher risk classes, there is 
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no prior external evaluation of the device by a notified body. Manufacturers do have to
 
draw up a state-
ment (Annex VIII MDD) with identification data and characteristics of the device, the identity of the pa-
tient (coded or not), the prescribing physician, and as applicable the hospital concerned. They must in 
addition declare that the essential requirements of Annex I MDD (among others, justification of material 
choice, biocompatibility requirements, and sterility requirements)
 
are fulfilled. However, they need not 
demonstrate that the 3D printed device is safer or more effective than (possibly) existing alternatives. 
According to the new EU regulations, stricter requirements for 3D printed medical devices made in larg-
er quantities will be imposed. This means that customisable medical devices will have to comply with 
the same conditions as standard medical devices for market access. An exception to the stricter legisla-
tion for standard medical devices was made for medical devices that are made in hospitals. Aside from 
the essential requirements of Annex I, the requirements of the Medical Devices Regulation (MDR) 
(among others, CE marking, assessment by a notified body for certain risk classes) are not applicable 
under a number of conditions. The new regulations took effect on May the 25th 2017 and will be directly 
applicable in spring 2020 for the MDR and spring 2022 for the In Vitro Diagnostics Regulation (IVDR). 
Thus, based on the above, there are currently (and in the future) different legal requirements between 
the different types of 3D printed medical devices and between 3D printed medical devices and the com-
parators (standard medical devices).  
 Liability: According to the principles of product liability, the producer is liable for any defect in its pro-
duct. In 3D printing, however, there is a deviation from the traditional chain of production, distribution 
and use. Who is the producer here? Many parties are involved in the production of 3D devices: the sur-
geon who makes the initial design, the software engineer who develops the 3D design, the producers of 
the 3D printer, material, software, and implant, the implanting surgeon, the hospital, etc. The Product 
Liability Directive (PLD)
9
 states that member states ‘must impose strict liability on’ producers when their 
products are defective and cause bodily injury, without the need for the victim to demonstrate that the 
producer has committed an error. The PLD also encompasses all medical devices that are made in the 
EU or imported. This strict liability is however only applicable to ‘industrially made products'. It has not 
yet been determined by the EU whether 3D printed medical devices fall under this PLD, and no EU 
case law yet exists on the concept 'industrially produced'. 
 Protection of person data: The 3D printing process unavoidably also involves the processing of health 
data of the individual patient. In addition, these data can be used for other than therapeutic purposes, 
e.g. for scientific research or reimbursement purposes (see below). Privacy legislation protects the pro-
cessing of personal data and has developed rules for this.
10
 It is very important to know who is regarded 
as "responsible for processing" by law. This person is in fact charged with almost all the legal obliga-
tions to guarantee protection of the processed data. Hospitals will generally be regarded as responsible 
for processing the personal data of the patient required for the 3D printing process. If hospitals out-
source 3D printing to an external producer, they will have to conclude a processing agreement with it. If 
the conditions of the privacy legislation are met, no specific problems arise in 3D printing. 
 Patients' rights: Patients have the right to be properly informed about alternatives. This could be an is-
sue if only one alternative is reimbursed in the health care system. 
4.2. Does comparing the new technology to the defined, existing comparator(s) 
point to any differences that may be legally relevant? 
Yes/No 
See above (section 4.1) 
 
  
                                                     
9 
 Council Directive 85/374/EEC of 25 July 1985 on the approximation of the laws, regulations and administrative provi-
sions of the Member States concerning liability for defective products, PB L 210 of 7/8/1985, pp. 29–33. 
 
10 
 EU: Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of indivi-
duals with regard to the processing of personal data and on the free movement of such data, PB L 281 of 23/11/1995 
pp. 0031 - 0050 and Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the 
protection of natural persons with regard to the processing of personal data and on the free movement of such data, and 
repealing Directive 95/46/EC, PB L 119 of 4/5/2016, pp. 1–88; Belgium: Law of 8 December 1992 on the protection of 
privacy in relation to the processing of personal data, Belgian Official Gazette, 18 March 1992 and its implementation 
decrees. 
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APPENDIX 3: TEC DOMAIN - 3D PRINTERS FOR IMPLANTS AND CUTTING 
GUIDES 
The technology 
Additive manufacturing (AM), or 3D printing, can no longer be considered as a ‘technique for pro-
totyping’. Recent advances in AM have resulted in its application in several sectors including 
healthcare. AM offers the capacity to engineer complex topography into materials with specific 
chemical, physical, and mechanical properties. 
This has allowed the production of personalised prosthesis, implants, and devices for medical 
applications. 3D printed medical implants and devices that are in clinical use today are construc-
ted predominantly with metals, ceramics, and organic polymers. 
Common types of 3D printers 
The type of 3D printer chosen for an application often depends on the application to which the 
final product will be used, that also defines the materials to those printers use and how the layers 
in the finished product are bonded (15). Although a wide range of 3D printing systems have been 
developed for industrial use; stereolithography (SLA), multijet modelling (MJM), selective laser 
sintering (SLS), and fused deposition modelling (FDM) are the main approaches that have been 
explored for medical applications (65). They can also be classified into: a) resin-based systems; 
b) powder-based systems; c) extrusion-based systems; and d) droplet-based systems. Each 
technique differs in the manner in which layers are built and printing materials used. 3D bioprin-
ting spans between laser-based, extrusion-based, and droplet-based systems. An overview of 
each printer technology is given below and summarised in Table A.6 (15,66).  
Stereolithography (SLA). Resin-based systems 
Amongst the photopolymerisation systems, stereolithography (SLA) was the first RP system 
known. In this process, a photopolymer is cured by a low-powder ultraviolet (UV) laser that solidi-
fies specific areas on the surface of the liquid through a chain reaction initiated by reactive spe-
cies generated by UV exposure. An SLA printer uses resin-based materials. Photocuring as a 
methodology for RP is particularly attractive for several reasons: high levels of build resolution, 
smooth part surfaces that do not typically require finishing processes, a good z axis strength due 
to chemical bonding between layers, fast builds possible, and the ability to print clear objects. 
Once the planar sections are completed, the prototype is then post-cured in a controlled furnace, 
or an ultraviolet curing apparatus, for a designated period of time, to allow final polymerisation 
(14). 
MultiJet modelling (MJM). Droplet-based systems 
Another cluster of 3D printing techniques includes droplet-based systems, where the liquid mate-
rial is deposited in a droplet form instead of a continuous flow. The material often turns solid after 
deposition via cooling (e.g., by crystallisation or vitrification), chemical changes (e.g., through the 
cross-linking of a polymer), or solvent evaporation (67). In the MultiJet printing or PolyJet techno-
logy, the heads are placed on a jetting head that deposits tiny droplets of ultraviolet (UV)-curable 
resin onto the build tray. After building each layer, UV bulbs alongside the jetting head harden the 
layer, and the tray moves down in the z direction a certain distance so that the next layer can be 
printed (68). The main advantage of MJM techniques is the high resolution comparable with laser-
based systems. However, printing materials used by jetting-based processes are limited and the 
high price of these printers make this technology more suitable for large-scale production. 
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Selective laser sintering (SLS). Powder-based systems 
An SLS printer uses powdered material as the substrate for printing new objects. A laser draws 
the shape of the object in the powder, fusing it together. Then a new layer of powder is laid down 
and the process repeats, building each layer, one by one, to form the object. Laser sintering can 
be used to create metal, plastic, and ceramic objects. The degree of detail is limited only by the 
precision of the laser and the fineness of the powder, so it is possible to create especially detailed 
and delicate structures with this type of printer (15). 
One of the major advantages of the SLS technology is the ability to process about any material in 
a powdered form: polymers, metals, ceramics, and a variety of composite materials such as glass 
reinforced polymers, metal/polymer composite, and metal/metal composites (69). Moreover, SLS 
does not require the use of organic solvents and can be used to make intricate biphasic scaffold 
geometries at both the macro and micro scale (70). These possibilities have opened the way for 
many medical applications, ranging from the fabrication of high-performance biomaterials such as 
HA-reinforced polyethylene composites for bioactive bone implants, to biodegradable polymers 
including polycaprolactone (PCL) (7,8,70) and poly-L-lactic acid (PLLA) (9) or nonbiodegradable 
polymers such as ultrahigh molecular weight polyethylene (UHMWPE) (10) and polyether ether 
ketone (PEEK) (71). 
Other powder-based technologies include direct metal laser sintering (DMLS), selective laser 
melting (SLM), and direct laser forming (DLF), all of which use concepts comparable to the SLS 
except that the material is fully melted rather than sintered. Electron beam melting (EBM) is an-
other powder-based system which differs from SLM only by the use of an electron beam as its 
power source instead of a high-power laser beam. DMLS and DLF has been investigated for the 
fabrication of porous titanium dental implants (67-69) (71-72) and Ti–6Al–4V scaffolds for bone 
tissue engineering and orthopaedic applications (73-75). The main disadvantages of SLS/SLM 
techniques are poor surface and dimensional accuracy, as well as low material properties that do 
not meet the prerequisite for industrial applications in terms of microstructure and mechanical 
strength. To address these drawbacks, post-processing treatments like depowdering, polishing, 
painting, heat-treatment, and furnace-infiltration can be employed (76). However, these steps are 
considered critical in direct RP for complex and controlled porous interconnected architectures 
(77). 
Fused Deposition Modelling (FDM). Extrusion-based technology 
Fuse deposition modelling (FDM) is a common material extrusion process and is trademarked by 
the company Stratasys (https://www.stratasys.com/). FDM is an affordable extrusion-based tech-
nology. A spool of thermoplastic filament feeds into an FDM extrusion head heated above the 
melting temperature of the material. FDM printers are much more common and inexpensive than 
the SLS type (12). An FDM printer uses a printhead similar to an inkjet printer (12). However, 
instead of ink, beads of heated plastic are released from the printhead as it moves, building the 
object in thin layers (12,15). This process is repeated over and over, allowing precise control of 
the amount and location of each deposit to shape each layer. Since the material is heated as it is 
extruded, it fuses or bonds to the layers below (15). As each layer of plastic cools, it hardens, 
gradually creating the solid object as the layers build. Depending on the complexity and cost of an 
FDM printer, it may have enhanced features such as multiple printheads (12). FDM printers can 
use a variety of plastics. In fact, 3D FDM printed parts are often made from the same thermoplas-
tics that are used in traditional injection moulding or machining, so they have similar stability, du-
rability, and mechanical properties (15). 
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Table A.6: 3D printing solutions and use 
Technology Best suited for 
SLA Best suited for smaller models with a very smooth surface finish. Able to produce very 
intricate details and features. Colours are limited. 
Material jetting The optimal solution for high detail, multi-colour, multi-material prints. Can also pro-
duce transparent parts. Surface finish is very smooth and models can be larger in size 
than FDM or SLA. More expensive than other AM technologies. 
SLS SLS can produce parts with very complex geometries and good strength. Parts are 
typically white with a matte-like grainy surface finish. Excellent for replicating bone. 
FDM FDM is ideal for geometrically basic surgical models that do not require a high level of 
detail or include intricate features. A large range of colours are available. Print layer 
lines will be visible. 
 
Thermal Inkjet Printing (TIJ) 
Inkjet printing is a “noncontact” technique that uses thermal, electromagnetic, or piezoelectric 
technology to deposit tiny droplets of “ink” (actual ink or other materials) onto a substrate accor-
ding to digital instructions. In inkjet printing, droplet deposition is usually done by using heat or 
mechanical compression to eject the ink drops. In TIJ printers, heating the printhead creates small 
air bubbles that collapse, creating pressure pulses that eject ink drops from nozzles in volumes as 
small as 10 to 150 picoliters. Droplet size can be varied by adjusting the applied temperature gra-
dient, pulse frequency, and ink viscosity. 
TIJ printers are particularly promising for use in tissue engineering and regenerative medicine. 
Because of their digital precision, control, versatility, and benign effect on mammalian cells, this 
technology is already being applied to print simple 2D and 3D tissues and organs (also known as 
bioprinting). TIJ printers may also prove ideal for other sophisticated uses, such as drug delivery 
and gene transfection during tissue construction (66).  
 
